Whole body FDG-PET in apparently-resectable NSCLC: Outline and design of the first randomised controlled trial of FDG-PET in NSCLC (Englisch)
- Neue Suche nach: Viney, R.
- Neue Suche nach: Fulham, M. J.
- Neue Suche nach: McCaughan, B. C.
- Neue Suche nach: Boyer, M. J.
- Neue Suche nach: King, M.
- Neue Suche nach: Kenny, P.
- Neue Suche nach: Hass, M.
- Neue Suche nach: Lowin, A.
- Neue Suche nach: McLean, J.
- Neue Suche nach: Cvetanovski, V.
- Neue Suche nach: Viney, R.
- Neue Suche nach: Fulham, M. J.
- Neue Suche nach: McCaughan, B. C.
- Neue Suche nach: Boyer, M. J.
- Neue Suche nach: King, M.
- Neue Suche nach: Kenny, P.
- Neue Suche nach: Hass, M.
- Neue Suche nach: Lowin, A.
- Neue Suche nach: McLean, J.
- Neue Suche nach: Cvetanovski, V.
In:
LUNG CANCER -AMSTERDAM-
;
29
;
253
;
2000
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Whole body FDG-PET in apparently-resectable NSCLC: Outline and design of the first randomised controlled trial of FDG-PET in NSCLC
-
Beteiligte:Viney, R. ( Autor:in ) / Fulham, M. J. ( Autor:in ) / McCaughan, B. C. ( Autor:in ) / Boyer, M. J. ( Autor:in ) / King, M. ( Autor:in ) / Kenny, P. ( Autor:in ) / Hass, M. ( Autor:in ) / Lowin, A. ( Autor:in ) / McLean, J. ( Autor:in ) / Cvetanovski, V. ( Autor:in )
-
Erschienen in:LUNG CANCER -AMSTERDAM- ; 29 ; 253
-
Verlag:
- Neue Suche nach: ELSEVIER
-
Erscheinungsdatum:01.01.2000
-
Format / Umfang:253 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.99424
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.99424 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 29
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Nicotine effects on proliferation and the bombesin-like peptide autocrine system in human small cell lung carcinoma SHP77 cells in cultureNovak, J. / Escobedo-Morse, A. / Kelley, K. / Boose, D. / Kautzman-Eades, D. / Meyer, M. / Kane, M. A. et al. | 2000
- 3
-
Epidemiology and treatment outcome of non small cell lung cancer (NSCLC) - Experience from rural South Indian populationRamassamy, M. et al. | 2000
- 3
-
Retrospective analysis of chemotherapy with Mitomycin, Ifosphamide and Cisplatinum (MIC) in advanced non-small cell lung cancer - Two years experienceHartung, H. / Skwarski, E. / Zarecki, J. / Skwarski, K. M. et al. | 2000
- 3
-
Ifosfamide (Holoxan) combination chemotherapy in NSCLC - Experience from IndiaBehera, D. / Aggarwal, A. / Sharma, S. C. / Gupta, D. / Jindal, S. K. et al. | 2000
- 4
-
Advanced non-small cell lung cancer (NSCLC) as a model for palliative chemotherapyCullen, M. H. et al. | 2000
- 4
-
Systemic chemotherapy as a primary treatment of brain metastases in patients with non-small cell lung cancer (NSCLC)Lee, J. S. / Pisters, K. M. / Komaki, R. / Terry, K. / Glisson, B. S. / Perez-Soler, R. / Fossella, F. V. / Shin, D. M. / Herbst, R. S. / Khuri, F. R. et al. | 2000
- 4
-
An economic analysis alongside a prospective randomized multicenter clinical trial of Cisplatin/Vinorelbine vs. Carboplatin/Paclitaxel for advanced nons mall cell lung cancerRamsey, S. D. / Moinpour, C. M. / Lovato, L. C. / Grevstad, P. K. / Presant, C. / Gandara, D. / Kelly, K. et al. | 2000
- 4
-
Examining the benefits of chemotherapy in subgroups of patients with inoperable non-small cell lung cancerBillingham, L. J. / Cullen, M. H. et al. | 2000
- 5
-
Bi-weekly taxol-carboplatin for advanced non small cell lung cancerRebischung, J. J. / Deletie, E. E. / Bizec, J. J. / Robin, N. M. et al. | 2000
- 5
-
Brain metastases of primary NSCLC treated with chemotherapy - 36 casesJovanovic, D. M. / Pajic, N. V. / Zdravkovic, A. N. et al. | 2000
- 5
-
A phase II trial of Paclitaxel, Carboplatin and Gemcitabine (Taxcarbogem) in the treatment of stage III non small cell lung cancer (NSCLC). Toxicity profileAlmenarez, J. / Murias, A. / Garcia, I. / Molano, F. / Aguiar, J. / Bohn, U. / Camacho, M. C. / Lopez, L. / Rodriguez, J. / Cabrera, L. et al. | 2000
- 5
-
Phase I study of dose-intensive carboplatin/paclitaxel (CB/PX) supported with filgrastim and haemopoietic progenitor cells in whole blood (BPC)Woll, P. J. / Pettengell, R. / Diffley, J. / Clayton, K. / Carmichael, J. et al. | 2000
- 6
-
A phase I/II study using oral topotecan (OT) with intravenous paclitaxel (P) as first-line therapy for patients (pts) with advanced non-small cell lung cancer (NSCLC)Eckardt, J. R. / Fanucchi, M. P. / Stewart, D. J. / Beckman, R. A. / Dobbs, T. W. / Wilson, J. J. / Ho, M. L. / Fields, S. Z. et al. | 2000
- 6
-
Paclitaxel and carboplatin in combination with gemcitabine (PCG): A phase I-II trial in advanced non-small cell lung cancer (NSCLC)Ceresoli, G. L. / Favaretto, A. / Paccagnella, A. / Barbieri, F. / Bearz, A. / Schiavon, A. S. et al. | 2000
- 6
-
Second-line (SL) weekly paclitaxel (P) in patients (pts) with advanced non-small cell lung cancer (NSCLC) failing first-line (FL) carboplatin/paclitaxel (C/P)Socinski, M. A. / Kies, M. / Unger, P. / Peterman, A. / Gillenwater, H. H. / Schell, M. / Bakri, K. et al. | 2000
- 6
-
Weekly chemotherapy with irinotecan plus a taxane in advanced non small cell lung cancer (NSCLC)Rich, R. S. / Argiris, A. / Peccerillo, K. / McKeon, A. / Gallipoli, M. / Burtness, B. A. / Murren, J. R. et al. | 2000
- 7
-
Phase II study of carboplatin (AUC 5) and vinorelbine in small cell lung cancer (SCLC)Dunlop, D. J. / O'Brien, M. / Lee, S. / Hill, S. / Thatcher, N. et al. | 2000
- 7
-
Phase II evaluation of paclitaxel by 96-hour infusion in stage IIIb and IV bronchioloalveolar carcinoma (BAC)Vance, R. B. / Crowley, J. J. / Gandara, D. et al. | 2000
- 8
-
A phase II study of cisplatin, etoposide, and paclitaxel (PET) with G-CSF in untreated patients with extensive small cell lung cancer: A Southwest Oncology Group trialKelly, K. / Bunn, P. A. / Lovato, L. / Crowley, J. / Livingston, R. B. / Gandara, D. R. et al. | 2000
- 8
-
Phase I/II study of initial high dose chemotherapy with ifosphamide/carboplatin/etoposide (ICE) followed by cisplatin/etoposide (PE) with concurrent thoracic irradiation (TRT) for limited-disease small cell lung cancer (LD-SCLC) (WJTOG9801)Yamaguchi, T. / Yokota, S. / Kudoh, S. / Takada, M. / Sugiura, T. / Negoro, S. / Yamamoto, N. / Fukuoka, M. / Ariyoshi, Y. et al. | 2000
- 8
-
A phase II trial of ifosfamide (I), etoposide (E), carboplatine (C) and cisplatin (CDDP) in small cell lung cancer (SCLC)Mahjoubi, R. / Llory, J. F. / Brugiere, O. / Vannetzel, J. M. et al. | 2000
- 9
-
Full dose (FD) chemotherapy (CT) plus lenograstim and low dose (LD) CT in elderly SCLC patients. A phase II randomized fonicap-GSTPV studyFavaretto, A. / Ardizzoni, A. / Tixi, L. / Antilli, A. / Boni, L. / Aitini, E. / Barbera, S. / Raimondi, M. / Ziade, A. / Porcile, G. et al. | 2000
- 9
-
Phase II trial of taxol and paraplatin in metastatic small cell lung cancer (SCLC). A G.F.P.C. Study (Groupe Francais de Pneumo-Cancerologie)Thomas, P. / Lena, H. / Robinet, G. / Paillotin, D. / DeLaval, P. / Clavier, J. / Blanchon, F. / Perdu, D. / Poirier, R. / Pommier de Santi, P. et al. | 2000
- 9
-
A Phase I-II trial with the association of Carboplatin and Epirubicin in Small Cell Lung Cancer with extensive disease: A Spanish Lung Cancer Group TrialBartomeu, M. / Gomez-Codina, J. / Artal, A. / Bover, I. / Barneto, I. / Trabal, I. / Anto, A. / Rosell, R. et al. | 2000
- 10
-
The catalytic topoisomerase II inhibitor dexrazoxane inhibits anthracycline-induced necrosis in mice: A new treatment of accidental extravasation of anthracyclinesLanger, S. W. / Sehested, M. / Jensen, P. B. et al. | 2000
- 10
-
Efficacy of reduced dose of IV topotecan (T) in relapsed small cell lung cancer (SCLC) patientsFields, S. Z. / Eckardt, J. R. / Zhang, L. / Poulin, R. K. / Rose, G. / Schiller, J. H. et al. | 2000
- 10
-
In vitro study of SCH 66336, a farnesyltransferase inhibitor, in non-small cell lung cancer (NSCLC) cell linesLoprevite, M. / Favoni, R. / Mazzanti, P. / de Cupis, A. / Pirani, P. / Ardizzoni, A. et al. | 2000
- 10
-
Single agent oral topotecan (OT) as first-line treatment for patients (pts) with extensive disease (ED) small cell lung cancer (SCLC) ineligible for standard therapy: A phase II studyEckardt, J. R. / Palmer, M. C. / Fanucchi, M. P. / Gralla, R. / Martins, H. / Poulin, R. / Fields, S. Z. et al. | 2000
- 11
-
Gemcitabine (G) followed by 2nd line Docetaxel (D) is feasible in advanced NSCLC: Results from a randomized phase II studyManegold, C. / Pitz, L. / Koschel, G. / Schott, K. / Waletzko, E. / Hruska, D. / Dornoff, W. / Gosse, H. / Gatzemeier, U. et al. | 2000
- 11
-
Experimental examination of the antitumor effect for the lung cancer of Docetaxel and PaclitaxelGika, M. / Inoue, Y. / Abiko, T. / Kawamura, M. / Kobayashi, K. et al. | 2000
- 11
-
The angiopoietins, tie2 and vascular endothelial growth factor are differentially expressed in the transformation of normal lung to non-small cell lung carcinomasWong, M. P. / Chan, S. Y. / Fu, K. H. / Leung, S. Y. / Cheung, N. / Yuen, S. T. / Chung, L. P. et al. | 2000
- 11
-
Reversal of cisplatin-resistance by 1,4-benzothiazepin derivative, JTV-519Nakamura, T. / Kaneko, N. / Tamura, T. / Chiwaki, F. / Koh, Y. / Akutagawa, S. / Takahash, F. / Koizumi, F. / Fukumoto, H. / Saijo, N. et al. | 2000
- 11
-
Four out of six human NYH small cell lung cancer cell lines resistant to ICRF-187 have either R162Q or Y165S functional mutations in the Walker ATP binding site of topoisomerase II alphaWessel, I. / Jensen, L. H. / Nitiss, J. L. / Jensen, P. B. / Sehested, M. et al. | 2000
- 12
-
Gemcitabine and Cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 Non-Small Cell Lung Cancer: A phase II study of the EORTC Lung Cancer Cooperative Group (EORTC 08955)Van Zandwijk, N. / Smith, E. F. / Kramer, G. W. / Schramel, F. / Gans, S. / Festen, J. / Termeer, A. / Schlosser, N. J. / Debruyne, C. / Curran, D. et al. | 2000
- 12
-
Phase II study of mitomycin, ifosfamide and gemcitabin (MIG) in advanced non-small-cell lung cancerMoller, G. / van Henten, A. / ten Velde, G. et al. | 2000
- 12
-
Phase II study of combination weekly gemcitabine and vinorelbine in patients with untreated or previously treated non-small cell lung cancerHerbst, R. S. / Khuri, F. R. / Jung, M. S. / Fossella, F. V. / Lee, J. S. / Glisson, B. / Shin, D. M. / Pisters, K. / Papadimitrakopoulou, V. / Kurie, J. et al. | 2000
- 13
-
Increased activity of the cisplatin to UCN-01 treatment sequence is associated with M-phase and p53-independent induction of p27/Kip 1 in Non-Small Cell Lung Carcinoma (NSCLC) cellsGumerlock, P. H. / Mack, P. C. / Lau, A. H. / Gandara, D. R. et al. | 2000
- 13
-
The relationship between HER2/neu expression and drug resistance for non-small cell lung cancerMatsuyama, K. / Oura, S. / Yoshimasu, T. / Sakurai, T. / Nakamura, T. / Kokawa, Y. / Ohta, H. / Naito, Y. et al. | 2000
- 13
-
Phase II study of docetaxel (DOC) and carboplatin (CP) as second-line treatment in patients (pts) with advanced non-small cell lung cancer (NSCLC)van Putten, J. W. / Slebos, D. J. / Groen, H. J. et al. | 2000
- 13
-
Phase II trial of MTA (AlimtaTM) and cisplatin in patients with advanced Non-Small Cell Lung Cancer (NSCLC)Shepherd, F. A. / Arnold, A. / Neville, A. / Dancey, J. / Rusthoven, J. / Fisher, B. / Eisenhauer, E. et al. | 2000
- 14
-
Correlation between docetaxel clearance and estimated cytochrome P450 (CYP3A4) activity by urinary metabolite of exogenous cortisol for patients with advanced non-small cell lung cancer (NSCLC)Yamamoto, N. / Tamura, T. / Kamiya, Y. / Kusaba, H. / Akimaya, Y. / Sekine, I. / Kunitoh, H. / Ohe, Y. / Kodama, T. et al. | 2000
- 14
-
Clinical dose-response relationships in non-small cell lung cancer: Implications for resistance mechanisms and resistance modulationStewart, D. J. / Dahrouge, S. / Banerjee, S. / Donker, R. et al. | 2000
- 14
-
OK432 with previous prescription of CDDP improve survival rate of lung cancer through the increase of anti-tumor lymphocyte adhesion to tumor endothelial cellSohara, Y. / Murayama, F. / Endo, S. / Yamaguchi, T. / Hasegawa, T. / Teduka, K. / Saito, N. et al. | 2000
- 15
-
Phase II study of paclitaxel and carboplatin for advanced Non-Small-Cell Lung-CancerScagliotti, G. V. / Novello, S. / Crin, L. / Ricci, S. / Selvaggi, G. / Galli, L. / Antonuzzo, A. / Mosconi, A. M. / Porrozzi, S. / Darwish, S. et al. | 2000
- 15
-
A multicenter, phase II study of combination paclitaxel/gemcitabine in previously untreated stage IV non-small cell lung (NSCLC) cancer patientsEdelman, G. / Melville, S. / Meyer, W. / Napier, S. et al. | 2000
- 15
-
Phase II study with gemcitabine and paclitaxel administered once every two weeks in chemonaive advanced stage non-small cell lung cancer (NSCLC) patientsFontaine, C. / Joos, G. / De Greve, J. / De Mey, J. / Van Klaveren, R. / Neyns, B. / Van de Velde, V. / Stappaerts, I. / Pinson, P. / Grauwels, D. et al. | 2000
- 15
-
Can chemosensitivity testing predict response to chemotherapy regimens in non-small cell lung cancer?Kawamura, M. / Abiko, T. / Gika, M. / Kobayashi, K. et al. | 2000
- 16
-
Sequential chemotherapy with carboplatin (C) and gemcitabine (G) followed by paclitaxel (P) in poor performance status (PS) and elderly patients (pts) with non-small cell lung cancer (NSCLC)Edelman, M. J. / Gandara, D. R. / Lau, D. / Lara, P. / Lauder, I. et al. | 2000
- 16
-
Phase II study of oxaliplatin (O) and paclitaxel (T) in advanced Non-Small Cell Lung Cancer (NSCLC)Mauer, A. M. / Otterson, G. A. / Szeto, L. L. / Hoffman, P. C. / Vokes, E. E. et al. | 2000
- 16
-
Phase II multicenter randomized trial of induction weekly paclitaxel (P) administered in combination with carboplatin (C) followed by weekly maintenance P vs. observation for patients (pts.) with advanced & metastatic non-small cell lung cancer (NSCLC)Belani, C. P. / Barstis, J. / Clark, R. / Mills, G. / Perry, M. / Nattam, S. et al. | 2000
- 17
-
Phase II study of paclitaxel, ifosfamide and carboplatin with filgrastim support in advanced non-small cell lung cancer (NSCLC)Mauer, A. M. / Ansari, R. H. / Hoffman, P. C. / Gabrys, T. G. et al. | 2000
- 17
-
Is cisplatin necessary for the treatment of non-small cell lung cancer (NSCLC)? - Analysis of consecutive trials of paclitaxel in NSCLCKubota, K. / Nishiwaki, Y. / Yokoyama, A. / Yoneda, S. / Tamura, T. / Watanabe, K. / Saijo, N. et al. | 2000
- 17
-
Paclitaxel and cisplatin in stage IV non-small cell lung cancer: A GETICS phase II studyJaremtchuk, A. V. / Aman, E. F. / Zarba, J. J. / Salvadori, M. / Alvarez, R. / Marmissolle, F. et al. | 2000
- 18
-
Multicenter phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma (MPM)van Haarst, J. W. / Burgers, J. A. / Manegold, C. H. / Baas, P. / Schouwink, H. / de Bruin, H. G. / de Jonge, M. J. / van Meerbeeck, J. P. et al. | 2000
- 18
-
Phase II trial of vinorelbine and oxaliplatin in patients with malignant pleural mesotheliomaSteele, J. P. / Shamash, J. / Evans, M. T. / Gower, N. H. / Rudd, R. M. et al. | 2000
- 18
-
Combined treatment of malignant mesothelioma (MM) of the pleura with high dose Methotrexate (Mtx), and interferons alfa (IFA) and gamma (IFG)Brodin, O. / Knuuttila, A. / Halme, M. / Strander, H. / LindEn, C. J. / Hillerdal, G. / Mattsson, K. et al. | 2000
- 18
-
Vinorelbine (Navelbine) given as a single agent for malignant pleural mesothelioma. Results from 65 patients at a single centreSteele, J. P. / Shamash, J. / Gower, N. H. / Evans, M. T. / Tischkowitz, M. D. / Rudd, R. M. et al. | 2000
- 19
-
ALIMTATM in combination with carboplatin demonstrates clinical activity against malignant mesothelioma in a phase I trialCalvert, A. / Hughes, A. N. / Calvert, P. M. / Plummer, R. E. / Highley, M. S. et al. | 2000
- 19
-
Taxotere in malignant pleural mesothelioma. A phase II clinical trialVorobiof, D. A. / Chasen, M. R. / Abratt, R. / Rapoport, B. / Cronje, N. / Fourie, L. / McMichael, G. / Hacking, D. et al. | 2000
- 19
-
Pathologic response with liposomal-entrapped cisplatin analog (L-NDDP) administered in patients (pts) with malignant pleural mesothelomia (MPM): Phase II clinical studyShin, D. M. / Walsh, G. L. / Smythe, W. R. / Ro, J. / Shin, H. J. / Swisher, S. / Lu, C. / Fossella, F. V. / Khuri, F. R. / Yalamanchili, A. et al. | 2000
- 20
-
The Big Lung Trial (BLT): A major randomised trial to determine the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer (NSCLC)Stephens, R. J. / Gower, N. H. / Spiro, S. G. / Rudd, R. M. et al. | 2000
- 20
-
Cisplatin, ifosfamide and mitomycin combination chemotherapy in the treatment of diffuse malignant pleural mesotheliomaMetintas, M. / Alatas, F. / Harmanci, E. / Erginel, S. / Metintas, S. et al. | 2000
- 20
-
Phase III trials in patients with advanced stage non-small cell lung cancer: The experience in North America from 1973-1994Breathnach, O. S. / Freidlin, B. / Conley, B. / Green, M. R. / Johnson, D. J. / Gandara, D. R. / O'Connell, M. / Simon, R. / Johnson, B. E. et al. | 2000
- 21
-
A phase II/III randomised comparison of gemcitabine/carboplatin (GC) with mitomycin, ifosfamide and cisplatin (MIC) in advanced non-small cell lung cancer (NSCLC)Rudd, R. M. / Gower, N. H. / James, L. E. / Gregory, W. / Eisen, T. Q. / Lee, S. M. / Harper, P. G. / Prendiville, J. / Spiro, S. G. et al. | 2000
- 21
-
Taxol (T), Ifosfamide (I) and Carboplatin (C) is an active combination for stage IIIB-IV Non Small Cell Lung Cancer (NSCLC). A multicenter validation studyZaniboni, A. / De Marinis, F. / Ardizzoni, A. / Portalone, L. / Boni, C. / Meriggi, F. / Di Molfetta, M. / Floriani, I. / Cafferata, M. A. et al. | 2000
- 21
-
A randomized phase III trial of the Southern Italy Oncology Group (G.O.I.M.). of mitomycin C plus vindesine and cisplatin (MVP regimen) versus vinorelbine plus cisplatin (PV regimen) in stage III-IV non small cell lung cancerGaletta, D. / Gebbia, V. / Riccardi, F. / Borsellino, N. / Gridelli, C. / Testa, A. / Durini, E. / Gebbia, N. / Colucci, G. et al. | 2000
- 22
-
A phase III randomized study of carboplatin and paclitaxel with or without amifostine in patients with non-small cell lung cancer (NSCLC)Belani, C. P. / Ansari, R. H. / Atkins, J. N. / Hon, J. K. / Modiano, M. R. / Budd, T. G. et al. | 2000
- 22
-
The efficacy of MVP (mitomycin C, vindesine and cisplatin) regimen as a salvage chemotherapy for non-small cell lung cancerAkiyama, Y. / Kunitoh, H. / Ohe, Y. / Yamamoto, N. / Kusaba, H. / Watanabe, H. / Sawada, M. / Sekine, I. / Kubota, K. / Tamura, T. et al. | 2000
- 22
-
Predicting response to second-line treatment with TaxotereR (Tax) in patients with non-small cell lung cancer (NSCLC) previously treated with platinum-based chemotherapyShepherd, F. A. / Hammershaimb, L. / Kim, Y. et al. | 2000
- 23
-
Phase I/II trial of cisplatin (CDDP), etoposide (ETP), and irinotecan (CPT-11) for the treatment of advanced non-small-cell lung cancer (NSCLC). Japan Clinical Oncology Group (JCOG) study 9512Makino, M. / Tsukada, H. / Yokoyama, A. / Kurita, Y. / Isobe, H. / Watanabe, K. / Saijo, N. et al. | 2000
- 23
-
A phase II study of UFT plus cisplatin (CDDP) in previously untreated patients with advanced non-small cell lung cancer (NSCLC)Nakanishi, Y. / Fujita, M. / Ninomiya, K. / Motohiro, A. / Kanegae, H. / Osaki, S. / Watanabe, K. / Kajiki, A. / Iwami, F. / Miyazaki, N. et al. | 2000
- 23
-
Randomized phase II study of docetaxel plus cisplatin versus docetaxel plus irinotecan in advanced non-small-cell lung cancer. A West Japan Thoracic Oncology Group StudySaito, H. / Yamamoto, N. / Negoro, S. / Nakagawa, K. / Matsui, K. / Kawahara, M. / Takada, Y. / Fukuoka, M. / Ariyoshi, Y. et al. | 2000
- 23
-
Chemotherapy in advanced NSCLC: Randomized comparison of ifosfamid/vindesin (IFO/VDS) versus mitomycin/ifosfamid/cisplatin (MIC)Serke, M. / Rucker, M. / Riedel, U. / Schoenfeld, N. / Loddenkemper, R. et al. | 2000
- 23
-
Immunohistochemical detection of mutant p53 protein in small-cell lung cancer: relationship to treatment outcomeGemba, K. / Ueoka, H. / Kiura, K. / Tabata, M. / Harada, M. et al. | 2000
- 24
-
A randomised trial comparing chemotherapy regimens with cisplatin (50 mg/m2) versus moderate doses of cisplatin and carboplatin in stage iv non-small cell lung cancerSculier, J. P. / Lafitte, J. J. / Thiriaux, J. / Alexopoulos, C. G. / Baumohl, J. / Koumakis, G. / Berghmans, T. / Ninane, V. / Mommen, P. / Paesmans, M. et al. | 2000
- 24
-
Intrathoracic hypotonic CDDP treatment (HPT) for malignant pleural effusion in patients with non-small cell lung cancer (NSCLC). A phase II studyIchinose, Y. / Seto, T. / Senba, H. / Yamamoto, H. / Ushijima, S. / Araki, J. / Inoue, Y. / Itoh, K. / Tamanoi, M. et al. | 2000
- 24
-
A phase I study of escalating doses of docetaxel (TXT) with G-CSF support in patients with advanced malignanciesMasters, G. A. / Brockstein, B. E. / Bertucci, D. / Mani, S. / Ratain, M. J. et al. | 2000
- 24
-
Tubulin mutations detected in circulating extracellular serum DNA of stage IIIB-IV non-small-cell lung cancer (NSCLC) patients treated with multiple chemotherapy (CT) regimensSanchez, J. / Nunez, L. / O'Brate, A. / Sancho, E. / Escuin, D. / Guillot, M. / Aracil, C. / Monzo, M. / Rosell, R. et al. | 2000
- 25
-
Paclitaxel and carboplatin adjuvant therapy for completely resected non-small cell lung cancer (stage IB-IIIB): A feasibility study of the Minnie Pearl Research NetworkGreco, F. A. / Burris, H. A. / Gray, J. R. / Hainsworth, J. D. et al. | 2000
- 25
-
A phase II trial of low-dose docetaxel (DCT) 60 mg/m2 in platinum-pretreated advanced non-small cell lung cancer (NSCLC)Kusaba, H. / Nakamura, Y. / Kunitoh, H. / Sekine, I. / Kubota, K. / Tamura, T. / Shinkai, T. / Yamamoto, N. / Ohe, Y. / Kodama, T. et al. | 2000
- 25
-
Paclitaxel-carboplatin alone or with gemcitabine or vinorelbine for stage IIIB and IV non-small cell lung cancer: Long-term follow-upGreco, F. A. / Burris, H. A. / Hainsworth, J. D. et al. | 2000
- 26
-
Induction therapy (IT) with paclitaxel (P) and CBDCA (C) followed by hyperfractionated radiotherapy (HFR) + weekly concurrent chemotherapy (WT) and subsequent manteinance therapy in unresectable NSCLC (Stage IIIA N2 bulky, Stage IIIB)Moscetti, L. / Cortesi, E. / Ramponi, S. / Corona, M. / Donato, V. / De Marinis, F. / Ammaturo, M. V. / De Paula, U. et al. | 2000
- 26
-
A phase I/II study of intensified cisplatin and high dose epirubicin with G-CSF support in patients with relapsed non-small cell lung cancerHuisman, C. / Herder, G. J. / Postmus, P. E. / Smit, E. F. et al. | 2000
- 26
-
Chemotherapy with Ifosfamide, Carboplatin and Etoposide in unresectable non-small cell lung carcinoma in an out-patient setting: A feasibility and quality of life studyKwa, H. / Willems, L. N. / Pieters, W. R. et al. | 2000
- 27
-
Randomized phase III trial of the Southern Italy Oncology Group comparing sequential ifosfamide + gemcitabine followed by cisplatin + navelbine (IG -> PN) versus the opposite sequence (PN -> IG) versus cisplatin + navelbine (PN) versus gemcitabine + cisplatin (GP) in stage III-IV non small cell lung cancer (NSCLC)Gebbia, V. / Galetta, D. / Caruso, M. / Borsellino, N. / Varvara, F. / Tirrito, M. / Testa, A. / Valenza, R. / Pandolfo, G. / Loizzi, M. et al. | 2000
- 27
-
Preliminary results of a randomised phase III trial comparing four cisplatin (P)-based regimens in the treatment of locally advanced and metastatic non-small cell lung cancer (NSCLC)Costa, A. / Barradas, P. / Cristovao, M. / Alves, P. / Melo, M. J. et al. | 2000
- 27
-
A phase III randomized study of intensive cisplatin with or without amifostine in patients with non-small cell lung cancer (NSCLC)Schiller, J. / Von Pawel, J. / Gatzemeier, U. / Arcenas, A. / Tester, W. / Kasimis, B. / Macha, H. et al. | 2000
- 27
-
A phase I study of dose-dense "alternating doublets" chemotherapy with filgrastim (rhG-CSF) support in advanced non-small cell lung cancer (NSCLC)Watson, S. M. / Gordon, G. S. / Mauer, A. M. / Rudin, C. R. / Hoffman, P. C. / Krauss, S. A. / Szeto, L. / Golomb, H. M. / Vokes, E. E. et al. | 2000
- 28
-
The final results of a randomized phase III trial comparing irinotecan (CPT-11) and cisplatin (CDDP) with vindesine (VDS) and CDDP in advanced non-small cell lung cancer (NSCLC)Takiguchi, Y. / Nagao, K. / Nishiwaki, Y. / Yokoyama, A. / Saijo, N. / Ohashi, Y. / Niitani, H. et al. | 2000
- 28
-
Randomized phase III trial compared cisplatin and irinotecan (CPT-P) versus cisplatin and vindesine (VDS-P) versus irinotecan alone (CPT) in patients with advanced non-small cell lung cancer (NSCLC) - The final reportKomiya, T. / Fukuoka, M. / Negoro, S. / Masuda, N. / Takada, Y. / Sugiura, T. / Ohashi, Y. / Niitani, H. et al. | 2000
- 28
-
Comparison of Tirazone (Tirapazamine) and cisplatin vs. etoposide and cisplatin in advanced non-small cell lung cancer (NSCLC): Final results of the international Phase III CATAPULT II TrialShepherd, F. / Koschel, G. / von Pawel, J. / Gatzmeier, U. / Van Zandwiyk, N. / Woll, P. / Van Klavren, R. / Krasko, P. / Desimone, P. / Nicolson, M. et al. | 2000
- 29
-
A phase III trial of taxol, etoposide phosphate and carboplatin (TEC) versus carboplatin, etoposide phosphate and vincristine (CEV) in previously untreated small cell lung cancer (SCLC)Gatzemeier, U. / Faderl, B. / Macha, H. / Kaukel, E. / Deppermann, K. M. / Bonnet, R. / Hessler, S. et al. | 2000
- 29
-
Chemotherapy for small cell lung cancer (SCLC) with holoxan (Ifosfamide) containing regimen - Experience from Northern IndiaBehera, D. / Aggarwal, A. / Sharma, S. C. / Gupta, D. / Jindal, S. K. et al. | 2000
- 29
-
A multicenter randomized phase III study comparing paclitaxel-cisplatin-etoposide (TEP) versus cisplatin-etoposide (EP) as front-line treatment in patients with small cell lung cancer (SCLC)Mavroudis, D. / Papadakis, E. / Veslemes, M. / Agelidou, M. / Tsiafaki, X. / Agelidou, G. / Pavlakos, G. / Anagnostopoulou, O. / Giannakakis, T. / Ziras, N. et al. | 2000
- 30
-
Phase II trial of sequential gemcitabine followed by cisplatin in patients with advanced non small cell lung cancerFoo, K. F. / Leong, S. S. / Ang, P. / See, H. T. / Ong, S. / Wee, J. / Fong, K. W. / Machin, D. / Tay, M. H. / Wong, Z. W. et al. | 2000
- 30
-
Prognostic factors for safety in non small cell lung cancer patients treated with Taxotere. A multivariate analysisBerille, J. / Olivares, R. / Hammershaimb, L. / Kim, Y. / Pham Tran, N. / Lelann, L. / Gamza, F. / Coughlin, S. / Schmidt, J. L. / Lebras, E. et al. | 2000
- 30
-
A randomized phase III study of irinotecan and cisplatin (CP) versus etoposide and cisplatin (EP) in extensive-disease small-cell lung cancer (ED-SCLC): Japan Clinical Oncology Group Study (JCOG 9511)Negoro, S. / Noda, K. / Nishiwaki, Y. / Kawahara, M. / Tamura, T. / Sugiura, T. / Yokayama, A. / Mori, K. / Fukuoka, M. / Yoshimura, K. et al. | 2000
- 30
-
Etoposide-cisplatin (EP) versus four-drug combination etoposide-cisplatin-epirubicin-cyclophosphamide (PCDE) in extensive disease small cell lung cancer (ED-SCLC). A FNCLCC phase III multicentre studyPujol, J. / Daures, J. / Riviere, A. / Quoix, E. / Depierre, A. / Breton, J. L. / Lemarie, E. / Poudex, M. / Milleron, B. / Moro, D. et al. | 2000
- 31
-
Gemzar and Navelbine in the treatment of patients with stage III b and IV non-small cell lung cancer. A phase II trialChasen, M. R. / Vorobiof, D. A. et al. | 2000
- 31
-
Gemcitabine (GEM) as single agent in second line treatment of non-small cell lung cancer (NSCLC)Mahjoubi, R. / Llory, J. F. / Brugiere, O. / Vannetzel, J. M. et al. | 2000
- 31
-
Phase II trial of mitomycin (MMC) and gemcitabine (GEM) in patients with advanced non small cell lung cancerReck, M. / von Pawel, J. / Seipel, G. / Seemann, M. / Gatzemeier, U. et al. | 2000
- 32
-
Docetaxel in patients with non-small cell lung cancer relapsed or progressed after first-line chemotherapyTeixeira, E. / Sotto-Mayor, R. / Borges, M. / Almodovar, T. / Duro da Costa, J. / Bugalho de Almeida, A. et al. | 2000
- 32
-
Gemcitabine-based combination chemotherapy for advanced non-small cell lung cancer: A new generation of therapy without cisplatinMok, T. / Nguyen, B. / Chan, A. / Zee, B. / Yim, A. / Yang, W. Y. / Wong, H. / Yeo, W. / Leung, T. W. / Chak, K. et al. | 2000
- 32
-
Single agent Gemcitabine for elderly patients with non small cell lung cancer (NSCLC): A phase II studyBurkes, R. L. / Wilson, J. / Shepherd, F. A. / Spadafora, S. / Iglesias, J. et al. | 2000
- 32
-
ALIMTA (TM) (pemetrexed, LY231514, MTA) in non-small cell lung cancerClarke, S. J. / Abratt, R. P. / Postmus, P. P. / Rusthoven, J. / Manegold, C. et al. | 2000
- 33
-
Salvage therapy with gemcitabine (Gem) in advanced non-small cell lung carcinoma (NSCLC) progressing after platinum-taxane chemotherapyLanger, C. / Schilder, R. / Millenson, M. / Kreamer, K. / Litwin, S. / Rosvold, E. / Kindsfather, S. et al. | 2000
- 33
-
Biological variables in non-small cell lung cancer: comparison between immunocytochemical determination on fine needle aspirates from surgical specimens and immunohistochemical determination on tissue sectionsBozzetti, C. / Franciosi, V. / Crafa, P. / Carbognani, P. / Rusca, M. / Nizzoli, R. / Guazzi, A. / Naldi, N. / Cocconi, G. et al. | 2000
- 33
-
Response to chemotherapy as a predictor of survival in advanced non-small cell lung cancer (NSCLC): Review of the Southwest Oncology Group (SWOG) databaseAkerley, W. / Crowley, J. / Giroux, D. / Gandara, D. et al. | 2000
- 33
-
Advanced age alone does not compromise outcome in fit non-small cell lung cancer (NSCLC) patients (pts) receiving platinum (DDP)-based therapy (Tx): Implications of ECOG 5592Langer, C. / Manola, J. / Bernardo, P. / Bonomi, P. / Kugler, A. / Johnson, D. et al. | 2000
- 34
-
Comparison of quality of life (QLT) outcomes for two chemotherapy regimens in non-small cell lung cancer (NSCLC)Moinpour, C. M. / Lyons, B. / Lovato, L. C. / Grevstad, P. K. / Kelly, K. / Crowley, J. / Gandara, D. et al. | 2000
- 34
-
Evaluating clinical versus statistical significance with the LCSS quality of life instrument and the Karnofsky Performance Status (KPS)Hollen, P. J. / Gralla, R. J. et al. | 2000
- 34
-
Assessing clinical benefit (CB) of chemotherapy (CT) in advanced non-small cell lung cancer elderly patientsLippe, P. / Silva, R. R. / Giuliodori, L. / Massacesi, C. / Battelli, N. / Cellerino, R. et al. | 2000
- 35
-
Multicenter randomized phase II trial assessing docetaxel (D) alternating with cisplatin (C) and vinorelbine (V) versus cisplatin (C) - vinorelbine (V) in stage IV non-small-cell lung cancer (NSCLC)Perol, M. / Lena, H. / Thomas, P. / Robinet, G. / Fournel, P. / Coste, E. / Belleguic, C. / Le Caer, H. / Blanchon, F. / Vergnenegre, A. et al. | 2000
- 35
-
Feasibility and safety of Navelbine oral (NVBpo) with an intrapatient dose escalation versus Navelbine intravenous (NVBiv) in advanced/metastatic non small cell lung cancer (NSCLC)Depierre, A. / Jassem, J. / Ramlau, R. / Karnicka-Mlodkowska, H. / Krawczyck, K. / Krzakowski, M. / Zatloukal, P. / Lemarie, E. / Hartmann, W. / Novakova, L. et al. | 2000
- 35
-
Vinorelbine in elderly patients with inoperable non-small cell lung cancer: A phase II studyBuccheri, G. / Ferrigno, D. et al. | 2000
- 36
-
Phase II study of oral topotecan (T) with cisplatin (C) in advanced, non-resectable NSCLC. A promising combinationPalshof, T. / Riviere, A. / Moreau, L. / Breton, J. L. / Hearn, S. / Fields, S. Z. / Ross, G. et al. | 2000
- 36
-
Topotecan and vinorelbine is as effective, but less toxic than platinum-containing regimens against NSCLC. Promising results of this outpatient regimen in a phase I/II trialStupp, R. / Bauer, J. / Perey, L. / Ketterer, N. / Fucina, N. / Perrier, R. / Leyvraz, S. et al. | 2000
- 36
-
Phase II study of the combination of vinorelbine, cisplatin, and tirapazamine in inoperable non-small cell lung cancer (NSCLC)Le Chevalier, T. / Gatineau, M. / Daniel, C. / Rixe, O. / Pailler, M. C. / Fizazi, K. / Fontaine, H. / Leon, V. / Rey, A. / Ruffie, P. et al. | 2000
- 37
-
Vinorelbine, ifosfamide and cisplatin (NIP) as first line chemotherapy in patients with non-small-cell lung cancer (NSCLC)Teixeira, E. / Sotto-Mayor, R. / Borges, M. / Bugalho de Almeida, A. et al. | 2000
- 37
-
Treatment results of vinorelbine (VIN) and carboplatinum (CAR) in unselected patients with non-small-cell lung cancer (NSCLC) - Analysis by means of a clinical tumor registryvon Bueltzingsloewen, F. J. et al. | 2000
- 37
-
Combined chemotherapy with AVP (Nidran + Vepasid + Cisplatin) in patients with extensive lung cancerBychkov, M. B. / Gorbunova, V. A. / Marenich, A. F. / Naschletashvili, D. R. et al. | 2000
- 37
-
Gemcitabine (G), ifosfamide (I), vinorelbine (N) in advanced non small cell lung cancer: A phase II studyMorere, J. F. / Pailler, M. C. / Bouillet, T. / Piperno-Neumann, S. / Blanchard, C. / Coulon, M. A. / Fain, O. / Hennebelle, F. / Breau, J. L. et al. | 2000
- 38
-
Prognostic factors in lung cancer: Is protocol inclusion in patients with lung cancer an independent prognostic factor? A retrospective studyBranle, F. / Paesmans, M. / Ninane, V. / Berghmans, T. / Vanderschueren, B. / Borges, M. / Mommen, P. / Sculier, J. P. et al. | 2000
- 38
-
Randomized adjuvant post- or pre-operative combined chemotherapy for curable patients with lung cancersAntypas, G. / Karrer, K. / Shields, T. W. et al. | 2000
- 38
-
Pemetrexed (ALIMTA), a novel multitargeted antifolate agent, is active alone and in combination in thoracic tumorsAdjei, A. A. / Calvert, A. H. / Hanauske, A. / Rusthoven, J. et al. | 2000
- 38
-
Dose intensity of irinotecan (CPT) combined with weekly cisplatin (DDP) and etoposide (ETOP) in patients (pts) with metastatic lung cancer (LC): Phase I/II study JCOG 9507Sekine, I. / Nishiwaki, Y. / Kakinuma, R. / Kubota, K. / Hojo, F. / Matsumoto, T. / Ohmatsu, H. / Goto, K. / Kodama, T. / Eguchi, K. et al. | 2000
- 39
-
Could carboplatin be inferior to cisplatin in management of small-cell lung cancer?Jezdic, S. / Jelic, S. / Nikolic-Tomasevic, Z. / Popov, I. / Radosavljevic, D. et al. | 2000
- 39
-
Targeting the cell kill of etoposide to brain metastases. A method for prophylactic cranial chemotherapy (PCC) in small cell lung cancerJensen, P. B. / Langer, S. W. / Sehested, M. et al. | 2000
- 39
-
Tandem high dose chemotherapy (THDC) in patients (pts) with small cell lung cancer (SCLC)Seifart, U. / Schroder, M. / Hans, K. / Ukena, D. / Thiele, K. P. / Neubauer, A. / Wolf, M. et al. | 2000
- 40
-
Paclitaxel, carboplatin and topotecan as initial therapy for small cell lung cancerHainsworth, J. D. / Gray, J. R. / Burris, H. A. / Greco, F. A. et al. | 2000
- 40
-
A phase I/II study of a 5-day schedule of intravenous topotecan (T) and etoposide (E) regimen in untreated small cell lung cancer (SCLC). A promising combination with potential for oral deliveryClark, P. / Sutton, P. / Smith, D. / Graham, R. et al. | 2000
- 40
-
Phase II study of topotecan (TOP) for relapsed small cell lung cancer (SCLC)Ogawara, M. / Negoro, S. / Nishiwaki, Y. / Fukuoka, M. / Watanabe, K. / Niitani, H. et al. | 2000
- 41
-
Prognostic factors for patients with small cell lung cancer: Analysis of a series of 763 patients with a minimal 5 years follow-up durationPaesmans, M. / Sculier, J. P. / Lecomte, J. / Thiriaux, J. / Libert, P. / Sergysels, R. / Bureau, G. / Dabouis, G. / Van Cutsem, O. / Mommen, P. et al. | 2000
- 41
-
Tolerability of a combination of carboplatin and etoposide phosphate in elderly patients with small cell lung cancer. A multicentric phase II clinical trialQuoix, E. / Breton, J. L. / Daniel, C. / Jacoulet, P. / Debieuvre, D. / Paillot, N. / Kessler, R. / Moreau, L. / Coetmeur, D. / Lamarie, E. et al. | 2000
- 41
-
Is chemotherapy for small cell lung cancer beneficial for elderly patients?Stephens, R. J. / Hopwood, P. / Johnson, D. H. et al. | 2000
- 41
-
Phase II study of irinotecan (CPT-11) combined with etoposide (VP-16) for previously untreated extensive stage small cell lung cancer (ES-SCLC)Kudoh, S. / Nakamura, S. / Komuta, K. / Nakano, T. / Fukuoka, M. / Ariyoshi, Y. et al. | 2000
- 42
-
Randomized trial of high-dose epirubicin-cisplatin (HDEP) versus etoposide-cisplatin (EP) in small cell lung cancer (SCLC). Study retrospective in older patientsCamps, C. / Artal, A. / Gomez-Codina, J. / Gonzalez-Larriba, J. L. / Barneto, I. / Carrato, A. / Isla, D. / Garcia-Giron, C. / Font, A. / Meana, A. et al. | 2000
- 42
-
How much impact had of etoposide (E) and cisplatin (P) on treatment outcome in small cell lung cancer (SCLC)? Analysis of data on limited stage disease (LD) from two decades (1973-1992)Lassen, U. N. / Osterlind, K. / Hansen, H. H. et al. | 2000
- 42
-
Topotecan in second-line treatment of small cell lung cancer reduced toxicity with individualized therapyKoschel, R. / Huber, R. M. / Gatzemeier, U. / Gosse, H. / von Pawel, J. / Hruska, D. / Mezger, J. / Saal, J. G. et al. | 2000
- 43
-
Phase II trial of weekly docetaxel (D) in second-line non-small cell lung cancer (NSCLC)Lilenbaum, R. / Schwartz, M. / Siegel, L. / Belette, F. / Blaustein, A. / Wittlin, F. / Cisneros, N. / Davila, E. et al. | 2000
- 43
-
Transsternal approach to closure of bronchopleural fistulas after pneumonectomy. A fifteen cases reportBeltrami, V. / Angelici, A. / Bertagni, A. / Bezzi, M. / Ciulli, A. / Forte, A. / Gallinaro, L. / Illuminati, G. / Montesano, G. / Prece, V. et al. | 2000
- 43
-
A phase I study of Docetaxel (D) and Oxaliplatin (L-OHP) as front-line treatment in metastatic breast cancer (MBC) and non-small cell lung cancer (NSCLC)Agelaki, S. / Kouroussis, C. / Mavroudis, D. / Kalbakis, K. / Souglakos, J. / Reppa, D. / Isbarach, I. / Mixaki, I. / Georgoulias, V. et al. | 2000
- 43
-
Phase I study of weekly Docetaxel (D) and Gemcitabine (G) in advanced non-small cell lung cancerKouroussis, C. / Kakolyris, S. / Stathopoulos, G. / Mavroudis, D. / Kalbakis, K. / Souglakos, J. / Vamvakas, L. / Mixaki, I. / Samonis, G. / Georgoulias, V. et al. | 2000
- 43
-
Docetaxel and irinotecan: An active non-platinum based regimen for the treatment of non-small cell lung cancerAdjei, A. A. / Hillman, S. / Verdirame, J. D. / Jett, J. et al. | 2000
- 44
-
Phase I/II study of weekly docetaxel (D) and carboplatin (C) in NSCLC IVGriesinger, F. / Leugering, J. / Metz, M. / Brittinger, G. et al. | 2000
- 44
-
A phase I trial of cisplatin (CDDP), docetaxel (DCT) and ifosfamide (IFX) in advanced non-small cell lung cancer (NSCLC)Kunitoh, H. / Sawada, M. / Watanabe, H. / Akiyama, Y. / Kusaba, H. / Yamamoto, N. / Sekine, I. / Ohe, Y. / Kubota, K. / Tamura, T. et al. | 2000
- 44
-
Phase II trial of taxotere and cisplatin in advanced non-small cell lung cancerHo, J. / Lam, W. / Ip, M. / Nguyer, T. / Tsang, K. W. et al. | 2000
- 45
-
Phase I study of docetaxel (DTX) and carboplatin (CBDCA) in advanced non-small cell lung cancer (NSCLC)Sawada, M. / Kubota, K. / Ito, R. / Watanabe, H. / Akiyama, Y. / Kusaba, H. / Yamamoto, N. / Sekine, I. / Kunitoh, H. / Ohe, Y. et al. | 2000
- 45
-
Phase I study of cisplatin, docetaxel and irinotecan for advanced non-small cell lung cancer (NSCLC)Kiura, K. / Ueoka, H. / Eguchi, K. / Segawa, Y. / Takigawa, N. / Kamei, H. / Shibayama, T. / Harita, S. / Hiraki, S. / Takata, I. et al. | 2000
- 45
-
Phase II study of Gemcitabine and Cisplatin in advanced non small cell lung cancer: Experience from EgyptGaafar, R. / Hamza, R. / Mansour, O. / Khaled, H. / Elserafi, M. / Karim, N. A. / Soliman, S. / Gadelmawla, N. et al. | 2000
- 45
-
Phase II study with Taxol (paclitaxel) and Gemzar (gemcitabine) in metastatic non-small cell lung cancer (NSCLC)Douillard, J. Y. / Lerouge, D. / Monnier, A. / Sun, X. S. / Haller, M. A. / Assouline, D. / Grau, B. et al. | 2000
- 46
-
Final results of a phase II trial of first-time therapy with gemcitabine (Gemtro) (G) and carboplatin (C) in patients (pts) with advanced non-small cell lung cancer (NSCLC)Jovtis, S. / Brocato, N. / Temperley, G. / Balbiani, L. / Comba, A. Z. / Rondinon, M. / Almira, E. / Martinez, J. / Bruno, M. / Maldonado, D. et al. | 2000
- 46
-
Vinorelbine/gemcitabine in advanced non-small-cell lung cancerPirker, R. / Krajnik, G. / Mohn-Staudner, A. / Thaler, J. / Greil, R. / Schmeikal, S. / Marhold, F. / Deutsch, J. / Malayeri, R. / Huber, H. et al. | 2000
- 46
-
Phase II study of taxol and gemcitabine in metastatic non-small cell lung cancerAuerbach, M. / Chaudhry, M. / Richards, P. / Clinthorne, D. et al. | 2000
- 47
-
Phase II trial with a new schedule of gemcitabine and cisplatin for the treatment of advanced non-small cell lung cancerChacon, J. I. / Andrade, J. / Lopez, L. / Martinez, B. / Cruz, M. et al. | 2000
- 47
-
Gemcitabine (GEM) as single agent in second line treatment of non-small cell lung cancer (NSCL)Mahjoubi, R. / Llory, J. / Brugiere, O. / Vannetzel, J. et al. | 2000
- 47
-
A phase II/III randomised comparison of gemcitabine/carboplatin (GC) with cisplatin/etoposide (PE) in patients with poor prognosis small cell lung cancer (SCLC)Robin, R. M. / James, L. E. / Gower, N. H. / Gregory, W. / Eisen, T. Q. / Harper, P. G. / Gilligan, D. / Ferry, D. / Spiro, S. G. et al. | 2000
- 47
-
Toxicity of single gemcitabine (GEM) in non-small cell lung cancer (NSCLC)Mali, P. / Liippo, K. / Nikkanen, T. A. et al. | 2000
- 48
-
Gemcitabine monotherapy (GEM) versus cisplatin-based chemotherapy in symptomatic advanced NSCLC: A prospective randomised comparison of symptom controlVansteenkiste, J. / Vandebroek, J. / Nackaerts, K. / Deschepper, K. / Van Kerckhoven, W. / Vandeurzen, K. / Deman, R. / D'Odemont, J. P. / Siemons, L. / Van Den Brande, P. et al. | 2000
- 48
-
Superiority of three-week vs. four-week schedule of cisplatin (CDDP) and gemcitabine (GEM): Results of a randomized phase II studySoto Parra, H. J. / Cavina, R. / Antonelli, G. / Latteri, F. / Sala, A. / Dambrosio, M. / Alloisio, M. / Morenghi, E. / Bufalino, R. / Santoro, A. et al. | 2000
- 48
-
Randomized phase I study of weekly or every other week gemcitabine (GEM) plus cisplatin (CIS) in advanced non-small cell lung cancer (NSCLC)van Zandwijk, N. / Schoemaker, N. / Baas, P. / Pluim, D. / Malliepaard, M. / Sparidans, R. W. / Schot, M. / Beijnen, J. H. / Schellens, J. H. et al. | 2000
- 49
-
CALGB Study 9431: A randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy (Ind CT) and concomitant chemoradiotherapy (XRT) for unresectable stage III non-small cell lung cancer (NSCLC)Vokes, E. E. / Leopold, K. A. / Herndon, J. E. / Crawford, J. / Perry, M. C. / Miller, A. A. / Green, M. R. et al. | 2000
- 49
-
Weekly gemcitabine with monthly cisplatin for advanced non-small cell lung cancerKurt, E. B. / Gulhan, M. / Erturk, A. / Alpar, S. / Capan, N. et al. | 2000
- 49
-
Assessment of tubulin mutations in a phase II study of biweekly gemcitabine/paclitaxel (T) in advanced non-small-cell lung cancer (NSCLC)Rosell, R. / O'Brate, A. / Sanchez, J. / Isla, D. / Felip, E. / Camps, C. / Gonzalez-Larriba, J. L. / Anton, A. / Carrato, A. / Azagra, P. et al. | 2000
- 49
-
A preoperative alternating chemotherapy and radiotherapy program for patients with stage IIIA (N2) non-small cell lung cancerTakamori, S. / Rikimaru, T. / Hayashi, A. / Tayama, K. / Mitsuoka, M. / Fujimoto, K. / Horiuchi, M. / Hayabuchi, N. / Oizumi, K. / Shirouzu, K. et al. | 2000
- 50
-
Randomised Phase II study of topotecan/cisplatin versus topotecan/etoposide in patients with untreated, extensive disease, small cell lung cancer (SCLC)Gervais, R. / Quoix, E. / Mattson, K. / Schramel, F. M. / Riviere, A. / Fields, S. / Wheatley, A. / Ross, G. et al. | 2000
- 50
-
Results of the phase I-II study of gemcitabine (GEM) in combination with oxaliplatin (OX) in patients (pts) with advanced non-small-cell lung cancer (NSCLC)Faivre, S. / Monnerat, C. / Raymond, E. / Taieb, J. / Adi Vago, N. / Vicente-Azevedo, J. / Roux, N. / kayitalire, L. / Armand, J. P. / Le Chevalier, T. et al. | 2000
- 50
-
Treatment of advanced non-small cell lung cancer with gemcitabine and cisplatinAlmodovar, M. / Dionisio, J. / Matias, D. / Duro da Costa, J. et al. | 2000
- 51
-
Phase I trial of topotecan (T) carboplatin (C) and etoposide (E) for extensive stage small cell lung cancer (ES-SCLC)Gillenwater, H. H. / McCune, J. S. / Donahue, A. E. / Faucette, S. R. / Shifflett, S. / Lindley, C. / Socinski, M. A. et al. | 2000
- 51
-
Weekly cisplatin-paclitaxel-topotecan (CPT) as front-line therapy for extensive disease small cell lung cancer (ED-SCLC). A Southern Italy Cooperative Oncology Group (SICOG) phase II studyFrasci, G. / Comella, P. / Panza, N. / Nicolella, G. / Natale, M. / De Cataldis, G. / Carreca, I. / Muci, D. / Brunetti, C. / Lamberti, A. et al. | 2000
- 51
-
Preliminary results of sequential dose-dense paclitaxel followed by topotecan in extensive small-cell lung cancer (SCLC): A phase II studyFelip, E. / Font, A. / Rosell, R. / Garrido, P. / Carrato, A. / Terrasa, S. / Mane, J. / Santome, L. / Baselga, J. et al. | 2000
- 51
-
EORTC LCCG Phase II study of topotecan in combination with cisplatin as second line chemotherapy of sensitive and refractory small cell lung cancer (SCLC)Ardizzoni, A. / Manegold, C. / Debruyne, C. / Gaafar, R. / Buchholz, E. / Dussenne, S. / Legrand, C. / King, K. / Giaccone, G. et al. | 2000
- 52
-
Phase II trial of topotecan and paclitaxel (TP) with G-CSF support alternating with etoposide and cisplatin (EC) in previously untreated extensive stage small cell lung cancer (ED-SCLC): A North Central Cancer Treatment Group studyJett, J. R. / Hatfield, A. / Bauman, M. / Hillman, S. / Soori, G. / Veeder, M. / Morton, R. et al. | 2000
- 52
-
Outpatient regimen of modified ice chemotherapy in a cohort of patients with small cell lung cancer: Survival and toxicityHand, S. / Baker, J. / Smith, A. P. / Macbeth, F. R. et al. | 2000
- 53
-
Paclitaxel (P) in combination with carboplatin (C) in the treatment of SCLC patients (a phase II study)Zarogoulidis, K. / Kontakiotis, T. / Hatziapostolou, P. / Tsianga, E. / Papakosta, P. / Goutsikas, J. / Patakas, D. et al. | 2000
- 53
-
A phase I/II study of antibody targeted therapy with CDP671/1 in advanced non-small cell lung cancer (NSCLC)Lorigan, P. / Carmichael, J. / Woll, P. J. / O'Byrne, K. / Browne, S. / Sopwith, M. et al. | 2000
- 53
-
Results of a dose-intense phase II study of a combination chemotherapy regimen with cisplatin (CDDP) and epirubicin (EPI) including medroxyprogesterone acetate (MPA) and recombinant interleukin 2 (rIL-2) in patients with inoperable primary lung cancerMantovani, G. / Maccio, A. / Massa, E. / Mudu, M. C. / Manca, G. / Mulas, C. / Massa, D. / Succu, G. / Astara, G. / Massidda, S. et al. | 2000
- 53
-
Is there a role for maintenance chemotherapy in patients treated for non-small cell lung cancer (NSCLC) stage IIIB and IV?Hirsh, V. / Langleben, A. / Ayoub, J. / Cormier, Y. / Salera, I. / Beaudoin, S. et al. | 2000
- 54
-
A phase I/II study of vinorelbine (NAV) and carboplatin (CARB) for advanced non-small cell lung cancer (NSCLC)Masters, G. A. / Neale, M. / Shevrin, D. / Kies, M. et al. | 2000
- 54
-
Is it a place for mitomycin C (MMC) in the treatment of non-small cell lung cancer (NSCLC)? A meta-analysisBerghmans, T. / Ghisdal, L. / Paesmans, M. / Branle, F. / Burniat, A. / Lafitte, J. J. / Lemaitre, F. / Mascaux, C. / Meert, A. P. / Steels, E. et al. | 2000
- 54
-
Gemcitabine, Ifosfamide and Navelbine: Activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC)Baldini, E. / Ardizzoni, A. / Cafferata, M. A. / Prochilo, T. / Boni, L. / Tibaldi, C. / Conte, P. / Rosso, R. et al. | 2000
- 55
-
Phase II study of an intensive single dose of irinotecan (CPT-11) and cisplatin (CDDP) every three weeks, in patients with advanced non-small cell lung cancerDomine, M. / Cardenal, F. / Massuti, B. / Carrato, A. / Felip, E. / Garrido, P. / Juan, O. / Artal, A. / Barneto, I. / Lopez-Vivanco, G. et al. | 2000
- 55
-
Vinorelbine (VNR), ifosfamide (IFO) and cisplatin (CDDP) as assitencial treatment in patients (PTS) with inoperable non small cell lung cancer (NSCLC)Montalar, J. / Morales, S. / Vadell, C. / Maestu, I. / Torregrosa, M. D. / Garcia-Gomez, R. / Camps, C. / Moreno, I. / Yuste, A. L. / Lorenzo, A. et al. | 2000
- 55
-
Phase II study of Exatecan Mesylate (DX-8951f) in advanced NSCLCTalbot, D. C. / White, S. / Mattson, K. V. / Manegold, C. / Jones, P. / Ranson, M. / Cheverton, P. / Sekiguchi, M. et al. | 2000
- 56
-
Phase I/II study of paclitaxel/vinorelbine (P/V) for advanced non-small cell lung cancer (NSCLC)Grunberg, S. M. / Greenblatt, M. / Ospina, D. / Valentine, J. et al. | 2000
- 56
-
Phase II Eastern Cooperative Oncology Group (ECOG) pilot study of paclitaxel (P), carboplatin (C) and Herceptin (H) in HER2/neu (+) advanced NSCLC: Preliminary analysisLanger, C. / Adak, S. / Thor, A. / Johnson, D. et al. | 2000
- 56
-
Phase I trial and pharmacokinetic study of ISIS 5132 combined with carboplatin and paclitaxel for advanced non-small cell lung cancerFidias, P. / Boral, A. / Shapiro, G. / Skarin, A. / Supko, J. / Eder Jr, J. P. / Holmlund, J. / Dorr, A. / Kwoh, J. / Geary, R. et al. | 2000
- 57
-
Randomized phase II trial comparing trastuzumab plus weekly docetaxel versus trastuzumab plus weekly paclitaxel in previously untreated advanced non-small cell lung cancer (NSCLC)Krug, L. M. / Miller, V. A. / Crapanzano, J. P. / Zakowski, M. F. / Ng, K. K. / Heelan, R. T. / Ross, J. / Sheehan, C. / Venkatraman, E. / Pizzo, B. A. et al. | 2000
- 57
-
The potential role of amifostine in the treatment of non small cell lung cancerCastiglione, F. / Porcile, G. / Gridelli, C. et al. | 2000
- 57
-
Gemcitabine + vinorelbine (GV) yields better survival than vinorelbine (V) alone in elderly non-small cell lung cancer (NSCLC) patients. Final analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trialFrasci, G. / Lorusso, V. / Panza, N. / Comella, P. / De Cataldis, G. / Micillo, E. / Iannelli, N. / Filippelli, G. / Muci, D. / Piantedosi, F. V. et al. | 2000
- 57
-
A phase II clinical and pharmacokinetic study of weekly paclitaxel in elderly patients with non-small cell lung cancerFidias, P. / Supko, J. / Martins, R. / Boral, A. / Skarin, A. / Johnson, B. / Carey, R. / Grossbard, M. / Vasconcelles, M. / Shapiro, G. et al. | 2000
- 58
-
Salvage gemcitabine (GEM) in platinum-treated non-small cell lung cancer (NSCLC): A phase II California cancer consortium trialLara, P. / Law, L. / Reddy, G. R. / Edelman, M. J. / Doroshow, J. H. / Lau, D. H. / Lenz, H. J. / Israel, V. / Albain, K. / Jaslowski, A. et al. | 2000
- 58
-
Phase II trial of alternating 4 chemotherapy regimens in non-small cell lung cancerStewart, D. J. / Shamji, F. / Maziak, D. / MacLeod, P. / Tomiak, E. et al. | 2000
- 58
-
Gemcitabine + ALIMTA in advanced non-small cell lung cancer (NSCLC): Why this regimen?Ettinger, D. S. / Bunn, P. A. / Le Chevalier, T. / Kelly, K. / Monnerat, C. et al. | 2000
- 59
-
Second-line treatment with single-agent gemcitabine (GEM) in patients (PTS) with advanced non-small-cell lung cancer (NSCLC)van Putten, J. W. / Baas, P. / Codrington, H. / Kwa, H. B. / Groen, H. J. et al. | 2000
- 59
-
Gemcitabine-cisplatin combination in metastatic non-small cell lung cancerMerimsky, O. / Wigler, N. / Schwarz, Y. / Greif, Y. / Mann, A. / Inbar, M. et al. | 2000
- 59
-
Integrated analysis for two randomized phase III studies comparing Taxotere at 75 mg/m2 and 100 mg/m2 to control regimens in non-small cell lung cancer (NSCLC) patients previously treated with a platinum-based chemotherapyKim, Y. P. / Koch, G. / Shepherd, F. A. / Fossella, F. / Hammershaimb, L. / Gamza, F. / Rodgers, A. / Bizzari, J. P. / Berille, J. / Durrleman, S. et al. | 2000
- 60
-
Preliminary results of a randomized study comparing the efficacy of 2 doses of docetaxel 100 mg/m2/3 weeks vs 75 mg/m2/3 weeks in treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of a previous cis-platin based chemotherapyQuoix, E. / Lebeau, B. / Jacoulet, P. / Ducolonne, A. / Moro, D. / Milleron, B. / Lemarie, E. / Pujol, J. L. / Brechot, J. M. / Zalcman, G. et al. | 2000
- 60
-
A multicenter, randomized phase III study of docetaxel + cisplatin (DC) vs docetaxel + carboplatin (DCb) vs vinorelbine + cisplatin (VC) in chemotherapy-naive patients (Pts) with advanced and metastatic non-small cell lung cancer (NSCLC)Belani, C. P. / Rodriguez, J. / von Pawel, J. / Pluzanska, A. / Gorbounova, V. / Millward, M. / Bosquee, L. / Kim, Y. / Gamza, F. / Berille, J. et al. | 2000
- 60
-
A prospective randomized trial of Taxotere versus best supportive care (BSC) in patients with non-small cell lung cancer (NSCLC) previously treated with platinum-based chemotherapy: Survival updateShepherd, F. / Dancey, J. / Ramlau, R. / Mattson, K. / Gralla, R. / Kim, Y. / Berille, J. et al. | 2000
- 61
-
Cisplatin/gemcitabine (CG) vs cisplatin/gemcitabine/vinorelbine (CGV) vs sequential doublets of gemcitabine/vinorelbine followed by ifosfamide/vinorelbine (GV/IV) in advanced non-small cell lung cancer. Interim analysis of a Spanish Lung Cancer Group (SLCG) phase III trialAlberola, V. / Camps, C. / Provencio, M. / Isla, D. / Vadell, C. / Perez Carrion, R. / Gonzalez-Larriba, J. L. / Azagra, P. / Diz, P. / Artal, A. et al. | 2000
- 61
-
Carboplatin (C) and docetaxel (D) in previously untreated advanced non-small cell lung carcinoma (NSCLC): A multicenter phase II trialJahanzeb, M. / Sarna, G. / Hirsch, R. / Radice, P. / Koletsky, A. / Martinez, M. / Kruglyak, E. / Wolin, E. / Comacho, E. / Kronish, L. et al. | 2000
- 61
-
A randomized phase III study of gemcitabine and carboplatinum versus vinorelbine and carboplatinum in advanced non small-cells lung cancer (NSCLC)Parente, B. / Barroso, A. / Conde, S. / Moura-Sa, J. / Seada, J. et al. | 2000
- 61
-
Lower recommended dose but not diminished efficacy obtained in elderly patients age 75 years or older in phase I study of cisplatin and docetaxel administered by 3 consecutive weekly infusions for advanced non-small cell lung cancerOhe, Y. / Niho, S. / Kakinuma, R. / Kubota, K. / Matsumoto, T. / Ohmatsu, H. / Goto, K. / Moriyama, E. / Hosomi, Y. / Uramoto, H. et al. | 2000
- 62
-
Phase II study of docetaxel (TXT) and carboplatin (CBDCA) combination in advanced non-small cell lung cancer (NSCLC). An ongoing studyGiannakakis, T. / Kakolyris, S. / Papadouris, S. / Theodoropoulos, I. / Kalbakis, K. / Androulakis, N. / Souglakos, J. / Agelaki, S. / Malliotakis, P. / Georgoulias, V. et al. | 2000
- 62
-
Phase I/II trial of weekly Docetaxel and Carboplatin in previously untreated patients with advanced non-small cell lung cancerKasturi, V. / O'Connell, T. / Gordon, J. / Walsh, W. / Horner, R. / Strauss, G. et al. | 2000
- 62
-
Phase I study of weekly docetaxel in patients with advanced refractory cancerTakada, M. / Yana, T. / Sakai, S. / Tsukiyama, S. / Higuchi, K. / Ueda, T. / Ohashi, K. / Hikita, T. / Kishino, B. / Nakagawa, K. et al. | 2000
- 63
-
Phase I/II study of biweekly paclitaxel and cisplatin in nonsmall cell lung cancer (NSCLC). Final result with QOL dataMelosky, B. / Gelmon, K. A. / Murray, N. / Page, R. / Ayers, D. / Lee, C. / Reilly, S. / Dulude, H. et al. | 2000
- 63
-
Phase I study of farnesyl tranferase inhibitors (FTI) SCH66336 with paclitaxel in solid tumors: Dose finding, pharmacokinetics, efficacy/safetyKhuri, F. R. / Glisson, B. S. / Meyers, M. L. / Herbst, R. S. / Thall, P. F. / Munden, R. F. / Bangert, S. / Cascino, M. / Shin, D. M. / Kurie, J. M. et al. | 2000
- 63
-
Weekly docetaxel as first-line therapy for elderly patients with advanced non-small cell lung cancer (NSCLC)Hainsworth, J. D. / Burris, H. A. / Morrissey, L. H. / Litchy, S. / Greco, F. A. et al. | 2000
- 64
-
Phase I trial in advanced malignancies with Liposome Encapsulated Paclitaxel (LEP)Treat, J. A. / Huang, C. / Damjanov, N. / Walker, S. / Drobins, P. / Gokhale, P. / Kopreski, M. / Massimini, G. / Rahman, A. et al. | 2000
- 64
-
D.I.G. - Phase I trial of sequential administration of docetaxel (D) followed 24 hs by gemcitabine (G) and irinotecan (I) in patients with solid tumorsRocha Lima, C. M. / Sherman, C. A. / Catapano, C. / Brescia, F. J. / Oakhill, G. / Bahadori, H. / Safa, A. / Green, M. R. et al. | 2000
- 65
-
First-line treatment of advanced non-small cell lung cancer with vinorelbine and gemcitabineBeinert, T. / Schweigert, M. / Kahnt, C. / Fleischhacker, M. / Werner, T. G. / Binder, D. / Mergenthaler, H. G. / Possinger, K. et al. | 2000
- 65
-
Clinical trial for the enhancement of antitumor effect of chemotherapeutic agent by means of low power laser irradiationShimatani, H. / Okunaka, T. / Tsuboi, M. / Furukawa, K. / Tsuchida, T. / Konaka, C. / Kato, H. et al. | 2000
- 65
-
Liposomal doxorubicin successful treatment in an elderly non-small cell lung cancer patient: A case reportCastiglione, F. / Galeasso, G. / Venturino, A. / Ostellino, O. / Porcile, G. et al. | 2000
- 65
-
A phase I dose escalation study of epidermal growth factor receptor (EGFR) tyrosine kinase (TK) inhibitor CP-358,774 in patients (pts) with advanced solid tumorsKarp, D. D. / Ferrante, K. J. / Tensfeldt, T. G. / Thurer, R. L. / LoCicero III, J. / Huberman, M. S. / Wirth, F. / Hellman, R. / Poulin, P. / Silberman, S. L. et al. | 2000
- 66
-
Docetaxel (Taxotere) as a basis of treatment for NSCLC in developing countriesKarim, A. B. / Hai, M. A. / Ansary, H. R. / Chowdhury, Q. / Samadder, D. / Tabassum, L. et al. | 2000
- 66
-
Phase I study of irinotecan and cisplatin with concurrent thoracic radiotherapy (TRT) in limited-stage small cell lung cancer (LS-SCLC)Fukuda, M. / Kinoshita, A. / Kuba, M. / Ichiki, M. / Rikimaru, T. / Takatani, H. / Soda, H. / Oka, M. / Kohno, S. et al. | 2000
- 66
-
Resistance to cisplatin renders high metastatic potential in human non-small cell lung cancer cell lineKim, J. / Soo Yoon, S. / Sung Ahn, K. / Hyung Choi, J. / Lee, H. I. et al. | 2000
- 67
-
Treatment of small cell lung cancer (SCLC) with topotecanMorales, S. / Balil, A. / Salud, A. / Antonio Carceller, J. et al. | 2000
- 67
-
A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancerSculier, J. P. / Lafitte, J. J. / Berghmans, T. / Thiriaux, J. / Lecomte, J. / Efremidis, A. / Ninane, V. / Paesmans, M. / Mommen, P. / Klastersky, J. et al. | 2000
- 67
-
Cisplatin (P), etoposide (E) and gemcitabine (G), in untreated patients with small cell lung cancer (SCLC): Preliminary results of a multi-institutional phase II trialDe Marinis, F. / Cortesi, E. / Paoluzzi, L. / Cipri, A. / Portalone, L. / Nelli, F. / Giampaolo, M. / Ariganello, O. / Diana, F. / Ramponi, S. et al. | 2000
- 67
-
A phase II trial of Topotecan (Hycamtin) with Ifosfamide (Duvaxan) plus Mesna (Mesnex) as first line treatment in patients (pts) with small cell lung cancer (SCLC). A preliminary reportVentriglia, M. / Cabrera, L. / Maidana, M. / Vigo, S. / Cilurzo, M. / Estevez, R. et al. | 2000
- 67
-
Topotecan (T) as second-line therapy following ifosfamide-carboplatin-etoposide (ICE) and maintenance for small cell lung cancer (SCLC)Ruotsalainen, T. / Mattson, K. et al. | 2000
- 68
-
Therapy of the small cell lung cancer - Comparison two established chemotherapy regime (ACO vs. CEV)Dittrich, I. / Floegel, R. / Liebetrau, G. / Guschall, W. R. et al. | 2000
- 68
-
Carboplatin, ifosfamide, etoposide and interferon alpha-2A combination chemoimmunotherapy in the treatment of small cell lung carcinomaMetintas, M. / Ucgun, I. / Alatas, F. / Metintas, S. / Harmanci, E. / Kolsuz, M. / Elbek, O. / Yurdasiper, A. / Erginel, S. et al. | 2000
- 68
-
Paclitaxel-based chemotherapy as second-line treatment in small cell lung cancer (SCLC)Novello, S. / Scagliotti, G. V. / Selvaggi, G. et al. | 2000
- 69
-
Phase I and pharmacokinetic (PK) study of Nedaplatin (254-S) in elderly patients with advanced non-small cell lung cancer (NSCLC)Kurata, T. / Tamura, T. / Yamamoto, N. / Sekine, I. / Kunitoh, H. / Ohe, Y. / Kodama, T. / Saijo, N. et al. | 2000
- 69
-
Combination of nedaplatin and vindesine for the treatment of relapsed or refractory non-small cell lung cancer (NSCLC)Fujiwara, K. / Takigawa, N. / Segawa, Y. / Eguchi, K. / Shibayama, T. / Kiura, K. / Ueoka, H. / Harada, M. et al. | 2000
- 69
-
A Phase I study of Nedaplatin (CDGP) and docetaxel (TXT) in patients with advanced non-small cell lung cancer (NSCLC)Saito, J. / Nakai, Y. / Koinumaru, S. / Matsuda, T. / Saijo, Y. / Nukiwa, T. et al. | 2000
- 70
-
Initial comparative study on the efficacy of single agent gemcitabine versus combination gemcitabine and cisplatin in Filipino patients with advanced non-small cell lung cancerGorospe, A. / Cristal-Luna, G. / Li, R. / Garcia, J. / Roces, L. / Lola, C. / Matunog, C. / Masadao, F. / Batac, E. / Bolinas, R. et al. | 2000
- 70
-
Preclinical and clinical overview of the novel platinum complex, ZD0473 (cis-amminedichloro[2-methylpyridine] platinum[II])Kelland, L. / Judson, I. / Koehler, M. / Stevens, T. / Roberts, D. et al. | 2000
- 70
-
A phase II study of Gemcitabine (G) plus Docetaxel (D) as first line chemotherapy for advanced NSCLC patients (PTS)Ventriglia, M. / Estevez, R. / Cabrera, L. / Spector, C. / Alvarez, A. A. / Cilurzo, M. et al. | 2000
- 70
-
An open-label, dose-escalation study of ZD0473 combined with paclitaxel in refractory solid malignanciesGatzemeier, U. / Kaye, S. B. / Groth, G. / Anthoney, D. A. / Cosaert, J. et al. | 2000
- 71
-
Pilot trial of ZD1839 (IressaTM), an oral inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase, in combination with carboplatin (C) and paclitaxel (P) in previously untreated advanced non-small cell lung cancer (NSCLC)Laurie, S. A. / Miller, V. A. / Johnson, D. / Ng, K. K. / Heelan, R. T. / Pizzo, B. A. / Perez, W. J. / Kris, M. G. / Ochs, J. / Averbuch, S. et al. | 2000
- 71
-
A Phase I intermittent dose-escalation trial of ZD1839 (IressaTM) in Japanese patients with solid malignant tumorsTamura, T. / Nakagawa, K. / Fukuoka, M. / Kudoh, S. / Yoshimura, N. / Negoro, S. / Takeda, K. / Kelly, H. et al. | 2000
- 72
-
Pilot study of carboplatin and docetaxel in patients with poor renal function and advanced non-small cell lung cancer (NSCLC)Okamoto, H. / Nagatomo, A. / Kunikane, H. / Watanabe, K. et al. | 2000
- 72
-
Objective regressions in non-small cell lung cancer patients treated in Phase I trials of oral ZD1839 (IressaTM), a selective tyrosine kinase inhibitor that blocks the epidermal growth factor receptor (EGFR)Kris, M. G. / Herbst, R. / Rischin, D. / LoRusso, P. / Baselga, J. / Hammond, L. / Feyereislova, A. / Ochs, J. / Averbuch, S. et al. | 2000
- 72
-
Prognosis of patients with myelotoxicity due to chemotherapy for bronchogenic carcinomaPalkova, I. / Babickova, L. / Merta, Z. et al. | 2000
- 72
-
Phase I study of irinotecan (CPT-11) and cisplatin (CDDP) with concurrent thoracic radiotherapy (TRT) in locally advanced non-small cell lung cancer (NSCLC)Nakamura, Y. / Fukuda, M. / Soda, H. / Ichiki, M. / Takatani, H. / Kanda, T. / Kinoshita, A. / Kuba, M. / Narasaki, F. et al. | 2000
- 73
-
Comparison of standard chemotherapy versus standard chemotherapy plus somatostatin or analogues in SCLCSougleri, M. / Giannios, J. / Asimakopoulos, C. / Safridi, C. / Christopoulou, A. / Kostalambrou, A. / Rogdakis, T. / Koukouras, D. / Ginopoulos, P. et al. | 2000
- 73
-
A phase I study of irinotecan (CPT-11) and gemcitabine combination as salvage treatment in patients with advanced non-small cell lung cancerKakolyris, S. / Kouroussis, C. / Mavroudis, D. / Souglakos, J. / Kalbakis, K. / Agelaki, S. / Vardakis, N. / Vamvakas, L. / Reppa, D. / Georgoulias, V. et al. | 2000
- 73
-
Salvage treatment of taxane-refractory advanced non-small-cell lung cancer with a cisplatin plus irinotecan (CPT-11) combinationKakolyris, S. / Androulakis, N. / Agelaki, S. / Mavroudis, D. / Souglakos, J. / Vardakis, N. / Reppa, D. / Samonis, G. / Georgoulias, V. et al. | 2000
- 74
-
Second line weekly docetaxel in advanced non small cell lung cancerSerke, M. / Rucker, M. / Schonfeld, N. / Loddenkemper, R. et al. | 2000
- 74
-
Effects of combination chemotherapy of Docetaxel and cis-platinum complexes in stage IV non-small cell lungNi, D. t. / Zhang, B. f. / Wu, C. g. / Chen, W. q. et al. | 2000
- 74
-
Paclitaxel (P) plus carboplatin (C) in advanced non-small cell lung cancer (NSCLC)Richardet, E. / Coppola, F. / Jovtis, S. / Fein, L. / Uranga, G. / Lewi, D. / Ventriglia, M. / Alasino, C. / Delfino, C. / Mickiewicz, E. et al. | 2000
- 74
-
Fractionated administration of cisplatin (CDDP) and irinotecan (CPT-11) in patients with stage IIIB and IV non-small-cell lung cancer (NSCLC): A phase II studyTakata, I. / Ueoka, H. / Kiura, K. / Hiraki, S. / Eguchi, K. / Okimoto, N. / Harita, S. / Yonei, T. / Kamei, H. / Segawa, Y. et al. | 2000
- 75
-
Preliminary results of a phase II randomized trial of docetaxel vs vinorelbine as second-line treatment in previously cisplatin-treated advanced non-small cell lung cancer (NSCLC)Marangolo, M. / Cognetti, F. / Di Costanzo, F. / Selvaggi, G. / Scagliotti, G. V. et al. | 2000
- 75
-
Paclitaxel/carboplatin as first line therapy in advanced (Stage IIIB/IV) NSCLCYaman, M. / Tosun, G. A. / Anakkaya, A. N. / Erturan, S. / Tutluoglu, B. et al. | 2000
- 75
-
Lung cancer and tobacco controlMotta, G. et al. | 2000
- 75
-
Aberrant nuclear mitosis associated with increased apoptosis from paclitaxel followed by flavopiridol in non-small cell lung carcinoma (NSCLC) cell linesGumerlock, P. H. / Mack, P. C. / Lau, A. H. / Edelman, M. J. / Gandara, D. R. et al. | 2000
- 75
-
Extensive clinical experience with taxotere (T) in 1st and 2nd line treatment in locally advanced or metastatic non small cell lung cancer (NSCLC)Wilke, H. / Von Pawel, J. / Boon Cher, G. / Krzakowski, M. / Pirker, R. / Morales, S. / Avril, I. / Manegold, C. et al. | 2000
- 76
-
Gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancerWu, M. F. / Tsai, C. M. / Wu, T. C. / Tsao, S. M. / Wu, M. H. / Chern, M. S. / Su, J. M. / Chou, M. C. / Perng, R. P. et al. | 2000
- 76
-
Combination of docetaxel and carboplatin in non-small cell lung cancer (NSCLC)Bando, H. / Miyata, J. / Sano, T. / Sumitomo, M. / Nagano, T. et al. | 2000
- 76
-
A phase I study of exisulind in previously treated patients with lung cancerKelly, K. / Mikhaeel, N. / Dempsey, E. / Magree, L. / Bunn Jr, P. A. et al. | 2000
- 76
-
Chemoradiotherapy in advanced lymphoepithelioma-like carcinoma (LELC) of lungHo, J. / Lam, W. / Ooi, G. / Tsang, K. / Wong, M. P. et al. | 2000
- 77
-
Mechanism of rising serum LDH caused by rhG-CSFSawa, T. / Yoshida, T. / Ikoma, T. / Ishiguro, T. / Kawada, M. / Ohno, Y. / Gotoh, K. / Fijiwara, H. et al. | 2000
- 77
-
Chemotherapy for small cell lung cancer (SCLC) patients with renal failureObana, T. / Tanio, Y. / Takenaka, M. / Watanabe, D. / Nakajima, S. / Okuda, Y. / Osanai, T. / Yasuda, J. et al. | 2000
- 77
-
Unexpected complication of gemcitabine in a patient with non-small cell lung cancer, already treated with low-dose methotrexate for rheumatoid arthritisGaldermans, D. / Bervoets, K. / Slabbynck, H. / Bedert, L. / Coolen, D. et al. | 2000
- 78
-
Chemotherapy and its pharmacokinetics (PK) study during maintenance hemodialysis in patients with primary lung cancer and renal failureWatanabe, R. / Takiguchi, Y. / Moriya, T. / Kimura, H. / Masuyama, S. / Oda, S. / Nagao, K. / Kuriyama, T. et al. | 2000
- 78
-
Phase I study of weekly cisplatin (C) and docetaxel (D) in patients with inoperable non-small cell lung cancer (NSCLC)Yana, T. / Takada, M. / Sakai, S. / Tsukiyama, S. / Higuchi, K. / Kishino, B. / Nakagawa, K. / Yamamoto, N. / Fukuoka, M. et al. | 2000
- 78
-
Vinorelbine, ifosfamide and cisplatin in non-small cell lung cancerTan, E. H. et al. | 2000
- 78
-
Phase II trial of high dose chemotherapy with amifostine and concurrent irradiation in limited disease small cell lung cancer (SCLC)Falchero, L. / Fournel, P. / Court-Fortune, I. / Hominal, S. / Rebattu, P. / Souquet, P. J. / Perol, M. / Janicot, H. / Riou, R. / Tchenio, X. et al. | 2000
- 79
-
Tumour staging and classification in lung cancer summary of the International SymposiumLopez-Encuentra, A. et al. | 2000
- 79
-
Multi-center study with paclitaxel (P)/carboplatin (C) in advanced or metastatic non-small cell lung cancer (NSCLC) patients (pts)Glorieux, P. / Ortmanns, P. / Marien, S. / Degives, R. / Degraeve, D. / Potvin, M. / Grauwels, D. / Schallier, D. et al. | 2000
- 79
-
Cisplatin-gemcitabine, vs. cisplatin-gemcitabine-vinorelbine, vs. cisplatin-gemcitabine-paclitaxel in advanced non-small-cell lung cancer. First-stage analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trialComella, P. / Frasci, G. / Panza, N. / Nicolella, G. / Manzione, L. / De Cataldis, G. / Cioffi, R. / Micillo, E. / Lorusso, V. / Bilancia, D. et al. | 2000
- 79
-
Treatment of advanced non-small-cell lung cancer failed to paclitaxel based therapy - Is Docetaxel (Taxotere*) useful?Kumar, R. et al. | 2000
- 80
-
Chemosensitivity test for unresectable lung cancer using mediastinoscopic biopsy specimensYoshimasu, T. / Oura, S. / Tanino, H. / Sakurai, T. / Nakamura, T. / Kokawa, Y. / Matsuyama, K. / Naito, Y. / Furukawa, T. / Yano, T. et al. | 2000
- 80
-
Can chemosensitivity testing evaluate the enhancement of chemosensitivity under hyperthermia?Abiko, T. / Inoue, Y. / Gika, M. / Kawamura, M. / Kobayashi, K. et al. | 2000
- 80
-
Phase I study of PKC412, a protein kinase C inhibitor, in combination with gemcitabine and cisplatin: Preliminary report of an ongoing phase I studyMonnerat, C. / Henriksson, R. / Raymond, E. / Berthaud, P. / Vicente-Azevedo, J. / Lavenius, E. / Dutreix, C. / Barbier, N. / Csermak, K. / Le Chevalier, T. et al. | 2000
- 80
-
Chemotherapy combined with radiosurgery in treatment of brain metastasis from non-small call lung cancerLi, J. H. / Yang, K. J. / Chen, Y. Q. et al. | 2000
- 81
-
Combined anti-cancer drug and hyperbaric oxygen therapy (HBO)Shima, K. / Wei, B. R. / Yoneyama, K. / Ichinose, S. / Konaka, C. / Kato, H. et al. | 2000
- 81
-
Desmoplastic small round cell tumour of the pleura: A case with unusual follow upOstoros, G. / Orosz, Z. / Kovacs, G. / Soltesz, I. et al. | 2000
- 81
-
Randomized study of vinorelbine (VRB) or vindesine (VDS) with cisplatin (P) and mitomycin (M) as induction chemotherapy in stage IIIB or IV non-small cell lung cancer (NSCLC) - Final resultsKawaguchi, T. / Kawahara, M. / Furuse, K. / Nishiwaki, Y. / Horai, T. / Saijo, N. / Hasegawa, K. / Ohashi, Y. / Niitani, H. et al. | 2000
- 82
-
Phase II study of Gemcitabine, Ifosfamide plus Vinorelbine (GIN) as a first-line chemotherapy in advanced non-small cell lung cancer (NSCLC): A promising non-cisplatin based regimenCastellano, D. / Lianes, P. / Arcediano, A. / Gomez-Martin, C. / Ciruelos, E. / Bezares, S. / Amador, M. L. / Paz-Ares, L. / Cortes-Funes, H. et al. | 2000
- 82
-
Phase II study of induction chemotherapy with gemcitabine (Gemtro) (G) and cisplatin (C) in patients (pts) with stage IIIA-IIIB non-small cell lung cancer (NSCLC)van Kooten, M. / Rosenberg, M. / Morero, J. / Vilanova, M. / Rojas, O. / Vicente, H. / Silva, C. / Chacon, R. D. / Orlando, M. et al. | 2000
- 82
-
Phase I trial of biweekly Gemcitabine Plus Vinorelbine in advanced solid tumors: A Dose-Finding StudyCastellano, D. / Hitt, R. / Lianes, P. / Amador, M. L. / Cortes-Funes, H. / Coloner, R. et al. | 2000
- 83
-
Paclitaxel (T) and carboplatin (C): A phase II study in advanced non-small cell lung cancer (NSCLC)Firvida, J. L. / Amenedo, M. / Salgado, M. / Gonzalez-Quintas, A. / Garcia Mata, J. / Losada, G. / Garcia-Gomez, J. / Calvo, M. / Rodriguez, R. et al. | 2000
- 83
-
Docetaxel plus Platinum regiments in in the treatement of NSCLC-single institution opinionKasan, P. / Toth, J. et al. | 2000
- 83
-
A phase II study of sequential administration of docetaxel and vinorelbine with gemcitabine for inoperable stage III or IV non-small cell lung cancer (NSCLC)Knuuttila, A. / Mali, P. / Hassi, E. / Isokangas, O. P. / Joensuu, H. / Mattson, K. et al. | 2000
- 83
-
Paclitaxel and Carboplatin plus Megestrol acetate in advanced non-small cell lung cancerThongprasert, S. / Cheewakriangkrai, R. / Eartongjit, J. et al. | 2000
- 83
-
Phase II trial of vinorelbine (VNR) and gemcitabine (GEM) in advanced non-small cell lung cancer (NSCLC)Garcia-Gomez, J. / Firvida, J. / Garcia-Mata, J. / Salgado, M. / Calvo, M. / Rodriguez, R. et al. | 2000
- 84
-
Cisplatin and gemcitabine is active and well tolerated in untreated locally advanced and metastatic non-small cell lung cancerGoksel, T. / Hatipoglu, O. / Ozturk, C. / Gorguner, M. / Kiyik, M. / Yilmaz, U. / Tasbakan, S. / Firat, H. / Cikrikcioglu, S. / Soyer, S. et al. | 2000
- 84
-
Evaluation of response, toxicity and survival in stage IIIB and IV non small cell lung cancer treated with chemotherapy with cisplatin and vinorelbine vs carboplatin and vinorelbineLerzo, G. L. / Temperley, G. / Fiore Marchesano, G. / Rosales, C. / Campos, C. / Gallego, A. et al. | 2000
- 84
-
Evaluation of serum alfa-1 acid glycoprotein (AAG) for efficiency of paclitaxel in patients with non-small cell lung cancer (NSCLC)Kashii, T. / Miwa, T. / Oda, H. / Sassa, K. / Maekawa, A. / Yamamoto, T. / Arai, N. / Matsui, S. / Yamashita, N. / Maruyama, M. et al. | 2000
- 84
-
A phase II study of docetaxel (taxotere) in combination with cisplatin in patients with metastatic (stage IV) or unresectable (stage IIIB) localized non-small cell lung cancer (NSCLC)Kim, H. K. / Lee, K. S. / Kim, J. S. / Kim, Y. K. / Park, H. S. / Chung, T. J. / Lee, S. N. / Kang, K. H. et al. | 2000
- 85
-
Transformation of CPT-11 to SN-38 in malignant pleural fluidMiyake, M. / Nakano, T. / Inoue, Y. / Iida, S. / Tonomura, A. / Togawa, N. / Hada, T. et al. | 2000
- 85
-
Carboplatin (C) and Gemcitabine (G) in advanced non small cell lung cancer (NSCLC): An effective and well tolerated regimenDomine, M. / Casado, V. / Estevez, L. G. / Leon, A. / Martin, J. I. / Castillo, M. / Robles, L. / Lobo, F. et al. | 2000
- 85
-
The usefulness of selective intraarterial preoperative adjuvant chemotherapy on advanced non-small cell lung cancer (NSCLC)Otani, Y. / Yoshida, I. / Sugano, M. / Morishita, Y. et al. | 2000
- 85
-
Association of serum cytokines (G-CSF, GM-CSF, IL-6, IL-11, thrombopoietin) and thrombocytopenia in non-small cell lung cancer (NSCLC) patients treated with paclitaxel and carboplatin (CBDCA)Miwa, T. / Kashii, T. / Oda, H. / Sassa, K. / Arai, N. / Matsui, S. / Yamashita, N. / Maruyama, M. / Kobayashi, M. et al. | 2000
- 86
-
Phase II study of Topotecan (T) IV with carboplatin (Carbo) in advanced NSCLCPujol, J. L. / von Pawel, J. / Tumolo, S. / Martoni, A. / Hearn, S. / Fields, S. Z. / Ross, G. et al. | 2000
- 86
-
Phase II randomised trial: Gemcitabine (GEM) + Vinorelbine (VNB) vs Gemcitabine + Vindesine (VDS) in Stage IIIB/IV -NSCLC- Elderly patients (pts). Italian Association of Hospital Pneumologists (AIPO)Santomaggio, C. / Portalone, L. / De Marinis, F. / Coppolino, S. et al. | 2000
- 86
-
Does chemotherapy duration impact on survival in patients with stage IV non-small cell lung cancer?Niho, S. / Kubota, K. / Moriyama, E. / Hosomi, Y. / Uramoto, H. / Nomura, M. / Goto, K. / Ohmatsu, H. / Matsumoto, T. / Kakinuma, R. et al. | 2000
- 86
-
Predictive value of in vitro chemosensitivity test using the 3-dimensional collagen gel droplet culture method in recurrent non small cell lung cancersKobayashi, H. / Higashiyama, M. / Kodama, K. / Minamigawa, K. / Takano, T. / Yokouchi, H. / Takami, K. et al. | 2000
- 87
-
Benefit of high-dose chemotherapy for small cell lung cancer (SCLC): An unsettled issueLeyvraz, S. / Perey, L. / Rosti, G. / Lange, A. / Pampallona, S. / Peters, R. / Humblet, Y. / Bosquee, L. / Pasini, F. / Marangolo, M. et al. | 2000
- 87
-
Endobronchial chemo-immunotherapy (ECIT) of non-operable lung cancer (LC): 10-year clinical experienceObodnikov, O. / Bagirov, M. / Sokolov, V. / Getman, V. et al. | 2000
- 87
-
Evaluation of the costs and efficacy of vinorelbine-cisplatin combination in nonsmall cell lung cancer - A developing country modelOzturk, C. / Kokturk, N. / Sener, M. / Levent, E. et al. | 2000
- 87
-
Clinical significance of the lymph node micrometastasis in Patients with early stage non small cell lung cancerBao, Y. H. / Shen, G. / Wu, J. D. et al. | 2000
- 89
-
Morbidity and mortality for pulmonary resections in lung cancer after induction treatmentAbolhoda, A. / Martin, J. / Ginsberg, R. J. / Rusch, V. / Bains, M. / Downey, R. / Korst, R. / Weigel, T. / Kris, M. G. et al. | 2000
- 89
-
Ten years' experience of induction therapy for locally advanced NSCLC; a single institution studySaito, Y. / Minami, K. / Kobayashi, M. / Tokunou, M. / Shomura, Y. / Omiya, H. / Imamura, H. / Yamaguchi, K. / Murata, T. / Okamura, A. et al. | 2000
- 89
-
Phase II study of induction chemotherapy in patients with stage IIIB NSCLCPitz, C. / Brutel de la Riviere, A. / van Beek, F. / Schlosser, N. / Hofman, P. / Dik, H. / Kersbergen, J. / Biesma, B. / Schramel, F. et al. | 2000
- 90
-
Early results of an international phase III study evaluating Taxotere as neo-adjuvant therapy for radically-treatable stage III NSCLCMattson, K. / Ten Velde, G. / Krofta, K. / Cour-Chabernaud, V. / Abratt, R. et al. | 2000
- 90
-
Randomized multicenter phase II study of chemotherapy followed by surgery versus surgery alone in stage I and II non-small cell lung cancer (NSCLC)Splinter, T. / Groen, H. / Smit, E. / Maat, A. / van Meerbeeck, J. et al. | 2000
- 90
-
Treatment with or without chemotherapy for locally advanced non small cell lung cancer (NSCLC): A systematic review by the European Lung Cancer Working PartyPaesmans, M. / Berghmans, T. / Vallot, F. / Branle, F. / Lafitte, J. J. / Lemaitre, F. / Mascaux, C. / Meert, A. P. / Steels, E. / Sculier, J. P. et al. | 2000
- 91
-
A phase II trial of preoperative concurrent chemoradiotherapy for stage IIIA non-small cell lung cancer with mediastinal lymph node involvementKim, J. / Shim, Y. M. / Kim, K. / Ahn, Y. C. / Park, K. / Kwon, O. J. / Kim, H. J. / Han, J. / Lee, K. S. et al. | 2000
- 91
-
Preliminary results of a randomized study on first and second line chemotherapy strategy in stage IV non-small cell lung cancer (NSCLC), assessing docetaxel (D) and cisplatin (C) until progressive disease (PD) then vinorelbine (V) versus V-C until PD then DDouillard, J. / Gervais, R. / Lacroix, H. / Le Groumellec, A. / Spaeth, D. / D'arlhac, M. / Clary, C. / Caillaud, D. / Coudert, B. / Maury, B. et al. | 2000
- 91
-
Surgical resection of non-small cell lung cancer with mediastinal lymph node metastases after induction chemotherapy with cisplatin and irinotecanDate, H. / Kiura, K. / Aoe, M. / Andou, A. / Shibayama, T. / Ueoka, H. / Harada, M. / Shimizu, N. et al. | 2000
- 91
-
French phase III trial of preoperative chemotherapy (PCT) in resectable stage I (except T1N0), II, IIIa non-small cell lung cancer (NSCLC)Depierre, A. / Milleron, B. / Chevret, S. / Moro, D. / Braun, D. / Quoix, E. / Lebeau, B. / Breton, J. L. / Lemarie, E. / Gouva, S. et al. | 2000
- 91
-
Second-line chemotherapy for recurrent non-small cell lung cancer: do new agents make a difference?Ferrigno, D. / Buccheri, G. et al. | 2000
- 92
-
Pathologic stage IIIb non-small cell lung cancer (NSCLC): Prolonged survival with consoloidation Docetaxel following concurrent chemoradiotherapy (SWOG 9504)Gandara, D. R. / Lovato, L. C. / Albain, K. S. / Leigh, B. / Lara Jr, P. N. / Crowley, J. J. / Livingston, R. B. et al. | 2000
- 92
-
Prospective randomized trial of postoperative adjuvant therapy in patients with completely resected stages II and IIIa non-small cell lung cancer: An intergroup trial (E3590)Keller, S. M. / Adak, S. / Wagner, H. / Herskovic, A. / Brooks, B. J. / Perry, M. C. / Livingston, R. B. / Johnson, D. H. et al. | 2000
- 92
-
A randomized phase III trial of sequential chemo-radiotherapy versus concurrent chemo-radiotherapy in locally advanced non small cell lung cancer (NSCLC). Interim analysis of toxicity. (GLOT-GFPC NPC 95-01 study)Fournel, P. / Robinet, G. / Thomas, P. / Souquet, P. / Lena, H. / Vergnenegre, A. / Michel-Montpeyroux, F. / Mornex, F. / Daures, J. P. et al. | 2000
- 93
-
Randomized chemoradiation for patients with locally advanced inoperable non-small cell lung cancer (NSCLC): Long-term follow-up of RTOG 92-04Komaki, R. / Seiferheld, W. / Ettinger, D. / Lee, J. S. / Movsas, B. / Sause, W. et al. | 2000
- 93
-
Induction treatment in patients with lung cancerPesek, M. / Novak, K. / Certikova, G. / Tauchman, A. / Eliasova, B. et al. | 2000
- 93
-
Limited toxicity in IIIA/B lung cancer patients treated with neoadjuvant concomitant chemo-twice daily radiation and G-CSF supportMalamud, S. / Culliney, B. / Pisch, J. / Yu, H. / Keller, S. et al. | 2000
- 93
-
Phase III comparison of sequential vs concurrent chemoradiation for pts with unresected stage III non-small cell lung cancer (NSCLC): Report of Radiation Therapy Oncology Group (RTOG) 9410Curran, W. / Scott, C. / Langer, C. / Komaki, R. / Lee, J. / Hauser, S. / Movsas, B. / Wasserman, T. / Russell, A. / Byhardt, R. et al. | 2000
- 94
-
Positron emission tomography (PET) assessment of response to neoadjuvant chemotherapy in stage II and IIIA non-small cell lung cancerHarris, M. / De Boer, R. / Ramdave, S. / Berlangieri, S. / Knight, S. / Clarke, C. P. / Daniel, F. / Cebon, J. / Scott, A. M. / Mitchell, P. L. et al. | 2000
- 94
-
Correlation of morphometric tumor response after induction chemotherapy with Docetaxel (D) or Paclitaxel (P) and Carboplatin (C) in stage III NSCLCGriesinger, F. / Paul, J. / Criee, C. P. / Schmidberger, H. / Dalichau, H. / Herse, B. / Hemmerlein, B. et al. | 2000
- 94
-
Neoadjuvant radiotherapy treatment for Stage N2 disease NSCLCPorhanov, V. A. / Poliakov, I. S. / Semendiaev, S. S. / Kononenko, V. B. / Bocharov, A. N. / Bodnia, V. N. / Mamelov, M. U. et al. | 2000
- 95
-
Induction therapy in NSCLC: Is clinical restaging predictive of pathological staging?Granone, P. M. / Margaritora, S. / Cesario, A. / Kawamukai, K. et al. | 2000
- 95
-
"Minimal N2-disease" (operable) stage IIIa non-small cell lung cancer: Prospectively randomized multicenter German phase-III-trial of surgery (S) followed by adjuvant radiotherapy (RTx) versus "Trimodality treatment" - Early results of feasibility and toxicity in this settingEberhardt, W. / Korfee, S. / Wagner, H. / Stamatis, G. / Bildat, S. / Stuschke, M. / Petersen, V. / Thetter, O. / Stuben, G. / Muller, M. R. et al. | 2000
- 95
-
Patterns of relapse of clinical N2 non-small-cell lung cancer (NSCLC) treated with preoperative chemotherapy: Should propylactic cranial irradiation be reconsidered?Andre, F. / Grunenwald, D. / Pignon, J. P. / Pujol, J. / Brichon, P. Y. / Brouchet, L. / Dujon, A. / Weestel, V. / Le Chevalier, T. et al. | 2000
- 95
-
Multistep phase H trial of induction chemotherapy followed by chemoradiation prior to surgery in patients with stage IIA and B non-small cell lung cancer (NSCLC)Cyjon, A. / Nili, M. / Fink, G. / Hefetz, M. / Kramer, M. / Fenig, E. / Sulkes, A. / Rakowsky, E. et al. | 2000
- 96
-
Concurrent radiation therapy in Small Cell Lung Cancer (SCLC) LD; Preliminary results from a Dutch pilot studyBelderbos, J. / van Meerbeeck, J. / Weenink, C. et al. | 2000
- 96
-
The survival of patients treated for limited stage small cell lung cancer has increased during the past 20 yearsJanne, P. A. / Freidlin, B. / Saxman, S. / Johnson, B. E. et al. | 2000
- 96
-
Small cell lung cancer (SCLC): Optimization of treatment by addition of prophylactic cranial irradiation (PCI) and interferon alfa (IFN)Lebeau, B. / de La Salmoniere, P. / Ozenne, G. / Blanchon, F. / Leclerc, P. / Coetmeur, D. / Thiberville, L. / Urban, T. / Legeais, A. et al. | 2000
- 97
-
Population-based outcome for small cell lung cancer (SCLC): Impact of standard management policies in British Columbia (BC)Murray, N. / Coldman, A. / D'yachkova, Y. / Trevisan, C. / Olivotto, I. / Hislop, G. et al. | 2000
- 97
-
Palliation and quality of life after hypofractionated radiotherapy (500 cGy x 12) plus Vinorelbine (NVB) in stage IIIA-B NSCLC patientsSilvano, G. / Campoccia, S. / Colosimo, S. / Moda, S. et al. | 2000
- 97
-
Early concurrent chemotherapy with carboplatin/etoposide plus normofractionated radiotherapy in limited stage small cell lung cancer (SCLC)Skacel, Z. / Marel, M. / Prausova, J. / Hovorkova, J. / Pipkova, R. / Melinova, L. / Kosatova, K. / St'astny, B. et al. | 2000
- 98
-
Intensive management for raising survival rate of small cell lung cancer (SCLC) with combined multi-therapy including traditional Chinese medicineCha, R. / Li, W. / Zheng, L. / Zeng, D. / Li, W. H. et al. | 2000
- 98
-
Concurrent cisplatin/etoposide (PE) and twice-daily thoracic radiotherapy (BID TRT) followed by weekly dose intensive regimen (CODE) with human granulocyte-colony stimulating factor (G-CSF) for limited stage (LS) small cell lung cancer (SCLC)Inoue, A. / Kubota, K. / Kodama, T. / Tamura, T. / Ohe, Y. / Kunitoh, H. / Sekine, I. / Nishiwaki, Y. / Saijo, N. et al. | 2000
- 98
-
The results of combined treatment of small-cell lung cancerJackevicius, A. / Cicenas, S. / Aleknavicius, E. et al. | 2000
- 98
-
Accelerated radiotherapy with docetaxel and cisplatin as induction and concomitant chemotherapy for stage III non-small cell lung cancerNyman, J. / Mercke, C. et al. | 2000
- 99
-
Three dimensional conformal radiotherapy and concurrent chemotherapy for unresectable stage III non-small cell lung cancerChoi, E. / Shin, K. / Ahn, S. / Yi, B. / Chang, H. S. / Suh, C. W. / Lee, J. S. / Kim, S. H. / Koh, Y. S. / Kim, W. S. et al. | 2000
- 99
-
Neoadjuvant therapy with Docetaxel (TAX) and Cisplatin (CIS) in patients (pts) with non-small cell lung cancer (NSCLC), stage IIIA, N2 is highly active with few toxicitiesBetticher, D. C. / Hsu Schmitz, S. F. / Gauthier, Y. / von Briel, C. / Roth, A. / Spiliopoulos, A. / Pless, M. / Stahel, R. / Weder, W. / Totsch, M. et al. | 2000
- 99
-
Induction (I) and concurrent (C) carboplatin/paclitaxel (C/P) with dose escalated thoracic conformal radiotherapy (TCRT) in stage IIIA/B non-small cell lung cancer (NSCLC): A phase I/II trialSocinski, M. A. / Halle, J. / Schell, M. / Clark, J. / Limentani, S. / Mitchell, W. / Fraser, R. / Rosenmann, J. et al. | 2000
- 100
-
Early whole brain concomitant radiotherapy-chemotherapy for non-small cell lung cancer (NSCLC) brain metastases. A phase 2 studyNgo Quy, C. / Haller, M. A. / Darut-Jouve, A. / Jolimoy, G. / Spaeth, D. / Beckendorf, V. / Bazarbachi, T. / Luporsi, E. / Coudert, B. / Martinet, Y. et al. | 2000
- 100
-
Outcome results of long term follow up, for population based cohort of patients with stage IIIA NSCLC treated with aggressive combined modality treatment approach in a prospective studyEl-Sayed, S. / Leylek, A. / Akra, M. / Mihalcioiu, C. et al. | 2000
- 100
-
A phase I/II study of Docetaxel (Taxotere) combined with concurrent radiation therapy in locally advanced non-small cell lung cancer (NSCLC)Aamdal, S. / Lauvvang, G. / Owre, K. / Hatlevoll, R. / Armellini, J. et al. | 2000
- 101
-
Brain metastases of lung cancer: Long-term results after concurrent chemoradiotherapy with cisplatin-etoposideReboul, F. / Brewer, Y. / Vincent, P. / Chauvet, B. / Felix Faure, C. F. / Taulelle, M. et al. | 2000
- 101
-
Sequential chemotherapy and radiotherapy in non-small cell lung cancerGaspar, L. F. / Susano, R. M. / Ortiz, M. / Teixeira, E. / Sotto-Mayor, R. et al. | 2000
- 101
-
Carboplatin/paclitaxel (C/P) or carboplatin/vinorelbine (C/V) followed by accelerated hyperfractionated conformal radiation therapy (AHCRT): A phase I dose esclation trial from the Carolina conformal therapy consortiumMarks, L. B. / Socinski, M. A. / Garst, J. / Sibley, G. S. / Blackstock, W. / Turrisi, A. / Herndon, J. / Zhou, S. / Anscher, M. / Crawford, J. et al. | 2000
- 102
-
Phase I study of irinotecan (CPT-11), cisplatin (cDDP) and radical thoracic radiation (TRT) in the treatment of locally advanced non-small cell lung carcinoma (NSCLC)Langer, C. / Movsas, B. / Huang, C. / Millenson, M. / Maiale, C. / Donahue, J. / Treat, J. et al. | 2000
- 102
-
Curative radiation therapy after VIP, a cisplatin-based chemotherapy, in stage IIIB non-small cell lung cancer (NSCLC): A phase II studySilvano, G. / Baldini, E. / Campoccia, S. / Tibaldi, C. / Cionini, L. et al. | 2000
- 102
-
Definitive concurrent chemoradiotherapy for stage IIIB non-small cell lung cancerAhn, Y. / Park, K. / Kim, D. / Kim, J. / Kim, W. S. / Huh, S. J. / Kim, H. J. / Kwon, O. J. et al. | 2000
- 103
-
Malignant Pleural Mesothelioma (MPM) treatment with Extrapleural pneumonectomy (EPP) and intra-operative Photodynamic therapy (iPDT) using mTHPC as photosensitiser: Long term outcome and toxicitySchouwink, H. / Baas, P. / Rutgers, E. T. / Oppelaar, H. / Zoetmulder, F. A. / van Zandwijk, N. / Stewart, F. A. / van Veen, R. et al. | 2000
- 103
-
Objective responses from adenovirus p53 administered by bronchoalveolar lavage in patients with bronchioalveolar cell lung carcinoma (BAC)Carbone, D. P. / Adak, S. / Schiller, J. / Kubba, S. / Slovis, B. / Coffee, K. / Worrell, J. / Thet, L. / Krozely, P. / Johnson, D. et al. | 2000
- 103
-
Adenoviral p53 [RPR/INGN 201] gene therapy for non-small cell lung cancer: A preliminary report of phase I trial in JapanFujiwara, T. / Kataoka, M. / Kanazawa, S. / Nakamura, A. / Tanaka, N. et al. | 2000
- 103
-
A phase I-II study of docetaxel (D) and gemcitabine (G) combination in patients (pts) with non-small cell lung cancer (NSCLC)Quantin, X. / Rebattu, P. / Pujol, J. / Morere, J. / Azarian, M. R. / Khial, F. / Dumortier, A. / Schuller-Lebeau, M. P. et al. | 2000
- 104
-
Sulcus superior tumors (SST); Results of resection in combination with preoperative and intraoperative radiotherapyvan der Sijp, J. R. / Jansen, P. P. / van Meerbeeck, J. P. / van Geel, A. N. et al. | 2000
- 104
-
The experimental study of heat-induced apoptosis in human lung adenocarcinoma cells in vitroKang, M. Q. / Zhou, L. / Chen, Z. Z. / Xie, J. W. et al. | 2000
- 104
-
Effect of advanced age on outcome in Radiation Therapy Oncology Group studies of locally advanced NSCLC (LA-NSCLC)Langer, C. / Scott, C. / Byhardt, R. / Movsas, B. / Sause, W. / Komaki, R. / Lee, J. / Curran, W. et al. | 2000
- 105
-
A phase I study of weekly gemcitabine as a radiosensitiser in stage III non-small cell lung cancerPrice, A. / Groen, H. / Gregor, A. / van Putten, J. / van der Leest, A. / Little, F. / Wets, M. / Jungnelius, U. et al. | 2000
- 105
-
Management of superior vena caval obstruction in carcinoma of the bronchus: Effectiveness of steroids, radiotherapy, chemotherapy and stents: A systematic reviewRowell, N. P. / Gleeson, F. V. et al. | 2000
- 105
-
Intrapleural thermotherapy for malignant pleural effusion caused by lung carcinomaKang, M. Q. / Zhou, L. / Chen, Z. Z. / Xie, J. W. / Lin, P. Q. et al. | 2000
- 105
-
Phase I study of carboplatin and vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancerCohen, E. E. / Hoffman, P. C. / Masters, G. T. / Daniel, H. J. / Mauer, A. M. / Rudin, C. M. / Watson, S. M. / Szeto, L. / Booda, M. / Vokes, E. E. et al. | 2000
- 105
-
Differentiation of malignant from benign solitary pulmonary lesions using chest radiography, spiral CT and HRCTSeemann, M. D. / Seemann, O. / Luboldt, W. / Bonel, H. / Sittek, H. / Dienemann, H. / Staebler, A. et al. | 2000
- 106
-
Concurrent chemo- (cisplatin and etoposide) radiation for stage III non-small cell lung cancer: Lack of correlation of p53 expression to treatment responseNavaratnam, S. / Brown Gladden, J. / Chowdhury, A. / El-Sayed, S. / Leylek, A. / Malik, U. / Mihalcioiu, C. / O'Connor, R. / Parham, S. / Tan, A. L. et al. | 2000
- 106
-
Role of paclitaxel in combined modality therapy for locally advanced non-small cell lung cancer (NSCLC): Multiinstitutional trials exploring sequential phase II studies of paclitaxel +/- carboplatin and radiation therapy (+/-hyperfractionation: HFXRT)Choy, H. / Schumaker, D. / DeVore, R. / Akerley, W. / Johnson, D. et al. | 2000
- 106
-
Combined cisplatinum and hypo-fractionated radical radiotherapy for locally advanced NSCLCMaguire, J. / Page, R. / Smith, N. / Kelly, V. et al. | 2000
- 107
-
A retrospective comparative study of surgery followed by chemotherapy (CT) vs. non-surgical management in limited disease (LD) small cell lung cancer (SCLC)Badzio, A. / Jacek, J. / Kurowski, K. / Karnicka-Mlodkowska, H. et al. | 2000
- 107
-
Neoadjuvant treatment with platinol compound-docetaxel in locally advanced and metastatic NSCLCBarak, F. / Schlanger, S. / Khinchin, I. / Weiler, Z. et al. | 2000
- 107
-
Place of surgery in the treatment of small cell lung carcinoma. Report of a serie of 27 patientsHominal, S. / Guibert, B. / Perol, M. / Thivolet, F. / Isaac-Pinet, S. / Loire, R. / Baulieux, J. / Gamondes, J. P. / Cordier, J. F. / Souquet, P. J. et al. | 2000
- 107
-
Neo-adjuvant chemotherapy in stage III NSCLC in the West of Scotland improves the potential for cureO'Rourke, N. / Armour, A. et al. | 2000
- 108
-
Phase II study of single agent ifosfamide in non-small cell lung cancerMilroy, R. / Sarvesvaran, J. / Howells, J. / Davidson, S. / McPhelim, J. / Towers, H. / Davis, A. / Jones, R. / Gravily, J. / Monie, R. et al. | 2000
- 108
-
Preoperative treatment with paclitaxel and carboplatin in locally advanced non small cell lung cancer (NSCLC): A phase II trialDe Candis, D. / Stani, S. C. / Bidoli, P. / Potepan, P. / Bedini, V. A. / Cataldo, I. / Michetti, G. / Navarria, P. / Bajetta, E. et al. | 2000
- 108
-
Lung cancer and occupational exposureNormand, J. C. / Souquet, P. J. / Bergeret, A. / Geriniere, L. C. / Larive, S. / Khouatra, C. / Prost, G. et al. | 2000
- 108
-
A phase II study of docetaxel (D)/carboplatin (C) in the treatment of NSCLC patientsZarogoulidis, K. / Kontakiotis, T. / Hatziapostolou, P. / Fachantidou, E. / Delis, D. / Goutsikas, J. / Konstantinidis, T. / Patakas, D. et al. | 2000
- 109
-
The management of locally advanced non-small cell lung cancer with combined modality therapySheehan, F. / Goddard, K. / Melosky, B. / Evans, K. / Murray, N. et al. | 2000
- 109
-
Dose escalation study of concurrent carboplatin and fluorouracil with radical radiotherapy [RT] in non-small cell lung cancerBall, D. / Millward, M. / Smith, J. / Mac Manus, M. / Wirth, A. / Ryan, G. / Toner, G. / Rischin, D. et al. | 2000
- 109
-
Vinorelbine, ifosfamide, and cisplatin combination as salvage chemotherapy in advanced non-small cell lung cancerPark, K. / Song, S. / Kim, W. / Park, C. / Kim, K. / Nam, E. M. / Yoon, S. S. / Lee, H. G. / Kang, W. K. / Kim, H. et al. | 2000
- 110
-
An effective treatment of lung cancer associated with malignant pleural effusion by intrapleural and intravenous chemotherapy plus pulmonary irradiationSu, W. / Lai, W. / Chen, H. / Huang, G. / Hsiue, T. / Chen, C. / Tsao, C. / Wang, N. et al. | 2000
- 110
-
A phase II trial of individualized response-based induction chemotherapy (IC) of mitomycin-C, vindesine, cisplatin (MVP) followed by thoracic radiotherapy (TRT) with daily low-dose carboplatin (CBDCA) for the treatment of unresectable stage III non-small-cell lung cancer (NSCLC)Shinbo, T. / Makino, M. / Tsukada, H. / Yokoyama, A. / Saitou, M. / Kurita, Y. et al. | 2000
- 110
-
Concurrent chemotherapy and radiotherapy in the treatment of unresectable stage III non-small cell lung cancerLeong, S. S. / Ong, Y. K. / Fong, K. W. / Lee, K. M. / Wee, J. / Foo, K. F. / Ang, P. / Tay, M. H. / See, H. T. / Wong, Z. W. et al. | 2000
- 110
-
Preliminary results of a Radiation Therapy Oncology Group trial (RTOG) 9705, a phase II study of postoperative adjuvant therapy in patients with completely resected stage II and stage IIIA non-small cell lung cancerGraham, M. / Paulus, R. / Wasserman, T. / Pilepich, M. V. / Machtay, M. / Komaki, R. / Akins, J. N. / Curran, W. et al. | 2000
- 111
-
A California Cancer Consortium phase II trial of concurrent twice-weekly paclitaxel, weekly carboplatin and radiation followed by paclitaxel/carboplatin consolidation for stage III non-small-cell lung cancerLau, D. / Ryu, J. / Gandara, D. / Edelman, M. / Israel, V. / Doroshow, J. et al. | 2000
- 111
-
Phase I study of weekly docetaxel (DTX) and carboplatin (CBDCA) with concurrent thoracic radiotherapy (TRT) for stage III non-small cell lung cancer (NSCLC)Murakami, H. / Kubota, K. / Ohe, Y. / Watanabe, H. / Sawada, M. / Akiyama, Y. / Kusaba, H. / Yamamoto, N. / Sekine, I. / Kunitoh, H. et al. | 2000
- 111
-
Gemcitabine (G) with concurrent chest radiation (XRT) followed by consolidation chemotherapy with gemcitabine plus cisplatin (CDDP): A phase I trial for patients with stage III non-small cell lung cancer (NSCLC)Fossella, F. V. / Zinner, R. G. / Komaki, R. / Jung, M. / Jhingran, A. / Glisson, B. S. / Pisters, K. M. / Stevens, C. W. / Khuri, F. R. / Kurie, J. M. et al. | 2000
- 111
-
A phase II study of induction chemotherapy (Ind CT) with CPT-11 and cisplatin followed by thoracic radiation (TRT) combined with weekly CPT-11 in patients with unresectable stage III non-small-cell lung cancer (NSCLC): A Japan Clinical Oncology (JCOG) 9706 TrialTakifuji, N. / Negoro, S. / Fukuoka, M. / Kawahara, M. / Ishizuka, N. / Saijo, N. / Shimoyama, M. et al. | 2000
- 112
-
A phase I study of carboplatin (Car) and docetaxel (Doc) followed by weekly Car/Doc with concurrent radiotherapy (CT/RT) in patients (pts) with stage III non-small cell lung cancer (NSCLC)Skarin, A. T. / Lynch, C. M. / Lucca, J. / Boral, A. L. / Lynch, T. J. / Herbst, R. S. / Berman, S. / Choi, N. C. / Mathisen, D. / Sugarbaker, D. J. et al. | 2000
- 112
-
Vinorelbine plus daily low-dose cisplatin with concurrent radiotherapy for the treatment of locally advanced inoperable non-small cell lung cancer: A phase I/II studyPless, M. / Kann, R. / Biedermann, B. / Landmann, C. / Herrmann, R. et al. | 2000
- 112
-
Induction treatment with mitomycin-ifosfamide-cisplatin (MIC) followed by concurrent radiotherapy and daily cisplatin in stage III non-small cell lung cancer: A getics phase II trialJaremtchuk, A. V. / Cedaro, L. / Zarba, J. J. / Keropian, M. A. / Ferro, A. M. / Jazey, P. G. / Mina, C. / Berardi, F. / Castagnino, R. / Bereihl, D. et al. | 2000
- 112
-
Multi-modality treatment of malignant mesothelioma with radical pleurectomy and decortication, intraoperative radiotherapy, and 3-D external beam radiotherapy and chemotherapyJablons, D. M. / Shu, H. / Roach, M. / Phillips, T. / Vignealut, E. / Chan, A. / Pickett, B. / Akazawa, P. / Xia, P. / Cameron, R. et al. | 2000
- 113
-
Gemcitabine and cisplatin as induction chemotherapy in stage IIIAN2/IIIB Non Small Cell Lung Cancer (NSCLC). A mono-institutional phase II study with 21 days scheduleMigliorino, M. / De Marinis, F. / Nelli, F. / Facciolo, F. / Ammaturo, M. V. / Ramponi, S. / Belli, R. / Ariganello, O. / Lampignano, M. / Martelli, M. et al. | 2000
- 113
-
Docetaxel plus cisplatin as neoadjuvant chemotherapy for unresectable stage III Non-Small-Cell Lung Cancer (NSCLC): A phase II studyDediu, M. / Horvat, T. / Tarlea, A. / Nicodin, A. / Movanu, M. / Radult, M. et al. | 2000
- 114
-
A phase II feasibility trial of gemcitabine and cisplatin before and after local treatment in locally advanced non-small cell lung cancerTsai, C. / Yang, C. / Wang, L. / Lee, Y. / Yen, S. W. / Huang, M. H. / Lui, L. T. / Lu, K. T. / Yang, P. C. / Perng, R. P. et al. | 2000
- 114
-
A phase I/II study of induction irinotecan (I), paclitaxel (P), and carboplatin (C) followed by concurrent thoracic (TXT) radiotherapy with irinotecan, paclitaxel, and carboplatin in unresectable, locally advanced non-small cell lung cancer (NSCLC)Mauer, A. M. / Haraf, D. C. / Rudin, C. M. / Vokes, E. E. et al. | 2000
- 114
-
Pilot study of induction carboplatin and paclitaxel followed by thoracic radiotherapy and concurrent daily cisplatin plus weekly paclitaxel in inoperable non-small-cell lung cancer (NSCLC)Grossi, F. / Tixi, L. / Scolaro, T. / Bacigalupo, A. / Ardizzoni, A. / Cafferata, M. A. / Rosso, R. / Vitale, V. et al. | 2000
- 115
-
Navelbine (NVB)-cisplatin (CDDP) induction chemotherapy (ICT) followed by radiation with or without daily carboplatin (CBDCA) in locally advanced unresectable non small cell lung cancer: Intermediate analysis of a french, multicenter phase III randomized trialDouillard, J. Y. / Riviere, A. / Ducolone, A. / Legroumellec, A. / Lechevalier, T. / Haller, M. A. / Deguiral, P. / Lemarie, E. / Clary-Meinesz, C. / Maury, B. et al. | 2000
- 115
-
A phase II study of continuous concurrent thoracic radiotherapy (TRT) in combination with mitomycin (M), vindesine (V) and cisplatin (P) in unresectable stage III non-small cell lung cancer (NSCLC)Atagi, S. / Kawahara, M. / Hosoe, S. / Ogawara, M. / Ishikawa, H. / Kawaguchi, T. / Kamitani, A. / Okishio, K. / Nobuyama, S. / Naka, S. et al. | 2000
- 115
-
Palliation and quality of life after hypofractionated radiotherapy (850 cGy x 2) plus vinorelbine (NVB) in stage IIIB-IV NSCLC patientsSilvano, G. / Campoccia, S. / Maranzano, E. / Lupatelli, M. et al. | 2000
- 115
-
The therapy of the inoperable non small cell lung cancer: Radiotherapy vs. radio-chemotherapyGuschall, W. R. / Schneemann-Heinze, S. / Floegel, R. / Liebetrau, G. / Dittrich, I. et al. | 2000
- 116
-
Phase I study for concomitant radiation therapy and weekly docetaxel and cisplatin in the treatment of advanced stage non-small cell lung cancerPark, C. / Wu, H. / Bang, Y. / Choi, E. / Ahn, Y. C. / Suh, C. / Park, K. / Kim, Y. W. / Park, B. J. / Lim, T. H. et al. | 2000
- 116
-
Phase II study of cisplatin (CDDP) and 5-fluorouracil (5-FU) with concurrent hyperfractionated thoracic radiotherapy (HFTRT) for locally advanced non-small-cell lung cancer (LA-NSCLC): A preliminary report from the Okayama Lung Cancer Study GroupSegawa, Y. / Ueoka, H. / Kiura, K. / Sakae, K. / Hiraki, Y. / Takigawa, N. / Eguchi, K. / Hiraki, S. / Harada, M. et al. | 2000
- 116
-
Daily low-dose paclitaxel and concurrent thoracic radiation in locally advanced NSCLC: Preliminary results of a radiobiology-based schedule in a phase I studyMinatel, E. / Franchin, G. / Mascarin, M. / Basso, B. / Locatelli, A. / Gigante, M. / Muzzio, P. C. / Trov, M. G. / Gobitti, C. et al. | 2000
- 117
-
A phase III study of stage III non small cell lung cancer treated with combined chemotherapy plus radiotherapy with or without paclitaxel as a radiosensitizerMorales, S. / Garcia, E. / Florian, J. / Alonso, M. et al. | 2000
- 117
-
Survival analysis of a serie of 100 patients with locally advanced unresectable non-small cell lung cancer (NSCLC) treated with a sequential schedule of cisplatin-based chemotherapy (CBC) and radiotherapy (RDT)Vadell-Nadal, C. / Algara, M. / Gallen, M. / Curull, V. / Perez, C. / Aunon, C. / Fabregat, X. et al. | 2000
- 117
-
Transbronchoscopic topochemotherapy and combination radiotherapy in non small cell lung cancerSarikos, G. / Baka, S. / Galaktidou, G. / Sapardanis, J. / Kortsaris, A. H. et al. | 2000
- 117
-
Phase I study of concurrent thoracic radiotherapy (TRT) in combination with mitomycin (M), cisplatin (P), vinorelbine (Vnr) in patients (pts) with unresectable stage III non-small cell lung cancer (NSCLC)Okishio, K. / Kawahara, M. / Hosoe, S. / Ogawara, M. / Nishiwaki, Y. / Kubota, K. / Hida, T. / Sugiura, T. / Nakagawa, M. / Yokota, S. et al. | 2000
- 118
-
Evaluation of radiation pneumotoxicity in patients with locally advanced non-small cell lung cancer (NSCLC) treated by concurrent versus sequential radiochemotherapy with vinorelbine plus cisplatin (V-P)Zemanova, M. / Zatloukal, P. / Petruzelka, L. / Havel, L. / Bortlova, A. / Homolka, J. et al. | 2000
- 118
-
An initial stent placement followed by chemo- and/or radiotherapy for superior vena cava syndrome caused by lung cancerFukuoka, K. / Kobayashi, S. / Yoneda, T. / Narita, N. / Imai, T. et al. | 2000
- 118
-
A randomized phase II study with concurrent versus sequential radiochemotherapy in non-small cell lung cancerZatloukal, P. / Petruzelka, L. / Zemanov, M. / Krejbich, F. / Havel, L. et al. | 2000
- 119
-
Multimodality treatment for stage III non small cell lung cancerFoo, K. F. / Tan, E. H. / Leong, S. S. / Agasthian, T. / Fong, K. W. / Wee, J. / Ong, S. / Ang, P. / Tay, M. H. / See, H. T. et al. | 2000
- 119
-
A phase I/II study of docetaxel (TXT) and cisplatin (CDDP) with concurrent thoracic radiotherapy (TRT) for locally advanced non-small-cell lung cancer (LA-NSCLC)Matsuo, K. / Hiraki, S. / Watanabe, Y. / Ueoka, H. / Kiura, K. / Moritaka, T. / Kamei, H. / Eguchi, K. / Hiraki, Y. / Harada, M. et al. | 2000
- 119
-
Gemcitabine-Cisplatin chemotherapy followed by radiotherapy in locally advanced non-small cell lung cancer (nsclc): A phase II retrospective analysisCrino, L. / De Marinis, F. / Scagliotti, G. / Rinaldi, M. / Maestri, A. / Mazzoni, F. / Di Stefano, A. / Cappuzzo, F. / Nelli, F. / Selvaggi, G. et al. | 2000
- 120
-
Combination of induction chemotherapy and immunotherapy in patients with locally advanced NSCLC: A preclinical laboratory studyRatto, G. B. / Alloisio, A. / Costa, R. / Melioli, G. G. et al. | 2000
- 120
-
Neoadjuvant chemotherapy with Taxol and Carboplatina in combined stage IB-IIIA non-small cell lung cancer (NSCLC) treatmentCicenas, S. / Vanakesa, T. et al. | 2000
- 120
-
Neoadjuvant treatment with vinorelbin and carboplatin in marginally resectable non-small cell lung cancer. Surgery followed by selective adjuvant chemotherapyKolek, V. / Grygarkova, I. / Klein, J. / Hajduch, M. et al. | 2000
- 120
-
Long-term results of two different neoadjuvant vinorelbine and cisplatin regiments in stage III non-small cell lung cancerSpasova, I. / Petera, J. / Hytych, L. / Marel, M. et al. | 2000
- 121
-
Systemic delivery of adenovirus-p53 with 2-methoxyestradiol inhibits lung metastasis in nude miceKataoka, M. / Schumacher, G. / Cristiano, R. J. / Atokinson, N. E. / Fujiwara, T. / Tanaka, N. / Roth, J. A. / Mukhopadhyay, T. et al. | 2000
- 121
-
Seamless lung cancer service provision: 2) A multidisciplinary approach to careDavidson, S. M. / Jones, R. / McPhelim, J. / Towers, H. / Bryden, F. / Millan, D. / Colquhoun, I. / McKay, S. / Milroy, R. et al. | 2000
- 121
-
Induction chemotherapy for stage III non-small cell lung cancer: The AASLC experienceMalayeri, R. / Pohl, G. / Krajnik, G. / Eckersberger, F. / Klepetko, W. / Muller, R. M. / Smolle-Juttner, F. M. / Maier, A. / Ambrosch, G. / Roger, A. M. et al. | 2000
- 121
-
Anti-Her2 MAb plus calicheamicin immunoconjugate linked on liposomal vinorelbine tartrate induces ADCC and apoptosis in HER2 positive NSCLCGiannios, J. / Michailakis, E. / Ginopulos, P. et al. | 2000
- 122
-
Combined regimen of cisplatin (CDDP), adriamycin (ADM) and a-2b interferon (IFN) in the treatment of advanced malignant pleural mesothelioma (MPM): A phase II multicenter trial of the Italian Group on Rare Tumors and Italian Lung Cancer Task Force (FONICAP)Santoro, A. / Tixi, L. / Soto Parra, H. J. / Ardizzoni, A. / Latteri, F. / Bretti, S. / Gravina, A. / Lionetto, R. / Bruzzi, P. / Rosso, R. et al. | 2000
- 122
-
Adoptive IL-2/LAK immunotherapy for malignant pleural effusionsKiselevsky, M. / Volkov, S. / Kasanova, G. / Kovrigina, A. / Rodionova, L. / Polotsky, B. / Bychkov, M. / Davydov, M. et al. | 2000
- 122
-
Intrathoracic infusion with a combination of cisplatin, OK-432, and minocycline for malignant pleural effusionIshimori, S. / Okada, S. / Yamauchi, H. / Satoh, S. et al. | 2000
- 123
-
Clarithromycin (CAM) regulates cytokine m RNA in non-small cell lung cancerMajima, T. / Mikasa, K. / Hamada, K. / Sakamoto, M. / Konishi, M. / Maeda, K. / Yoshimoto, E. / Murakawa, K. / Takahashi, K. / Kita, E. et al. | 2000
- 123
-
Superior vena cava syndrome (SVCS) in lung cancer patients: A multivariate analysis of clinical dataMartins, S. J. / Pereira, J. R. / Ikari, F. K. / Nikaedo, S. M. et al. | 2000
- 123
-
Treatment of non small cell lung cancer with interferon-gamma. Interaction with other cytokinesSarikos, G. / Baka, S. / Galaktidou, G. / Sihletidis, L. / Kortsaris, A. H. et al. | 2000
- 123
-
Fourteen-member macrolide cooperates with chemotherapeutic agent to enhance apoptosis in human non-small lung cancer cells: Implication for p53 upregulation induced by the macrolidesSassa, K. / Maruyama, M. / Kashii, T. / Fujita, T. / Araya, J. / Oda, H. / Hayashi, R. / Matsui, S. / Sugiyama, E. / Yamashita, N. et al. | 2000
- 123
-
Chemotherapy for metastatic non-small cell lung cancer (NSCLC): A single institution experience in BrazilPereira, J. R. / Martins, S. J. / Ikari, F. K. / Nikaedo, S. M. et al. | 2000
- 124
-
Integration of surgery in the pluridisciplinary approach of non-small cell cancer patients improves the outcomeIoan, A. / Ciuleanu, T. / Guttman, T. / Ghilezan, N. et al. | 2000
- 124
-
Oncolyn causes clinical remission of diffuse malignant pulimonary imesothelioma and other solid tumors in manDjang, A. H. et al. | 2000
- 124
-
Synergistic effect of ONYX-015 and chemotherapy on lung cancer cell lines and primary culturesYou, L. / Yang, C. / Clare-Macy, C. / Jablons, D. M. et al. | 2000
- 124
-
High frequency electrical knife through fibrebronchoscope in treatment of tracheal tumor with large airway obstructionWang, G. Q. / Xie, M. J. / Chi, F. / He, Y. et al. | 2000
- 125
-
Pulmonary blastoma - 11 years experienceZaidi, A. / Barry, J. / Macbeth, F. R. / Kulatilake, N. et al. | 2000
- 125
-
High prevalence of atypical adenomatous hyperplasia of the lung in autopsy specimens from elderly patients with malignant neoplasmsYokose, T. / Ito, Y. / Ochiai, A. et al. | 2000
- 125
-
Pulsed paclitaxel radiosensitization for thoracic malignancy: A therapeutic approach based on preclinical research of human lung cancer cellsChen, Y. / Pandya, K. / Okunieff, P. / Feins, R. / Keng, P. / Smudzin, T. / Raubertas, R. / Rosenblatt, J. et al. | 2000
- 125
-
Introduction of resistance to ONYX-015 by re-expressing p 14ARF in human mesothelioma cells: Implications for therapyYang, C. / You, L. / Song, J. / Jablons, D. M. et al. | 2000
- 125
-
Brain relapse in patients with locally advanced non small cell lung cancer (LANSCLC): Is there a place for prophylactic cranial irradiation (PCI)?Le Pechoux, C. / Laplanche, A. / Bretel, J. J. / Tarayre, M. / Girard, P. / Grunenwald, D. / Ruffie, P. / Le Chevalier, T. et al. | 2000
- 126
-
The influence of the post-operative radiotherapy and analysis of the risk factors on the survival in patients in stage IIIA (N2 disease) NSCLCChabowski, M. / Orlowski, T. M. / Dziedzic, D. / Kupis, W. / Roszkowski, K. et al. | 2000
- 126
-
Primary surgery with adjuvant chemoradiationtherapy in patients (pts) with small cell lung cancer (SCLC) (T1-2, N0, M0)Seifart, U. / Schroder, M. / Hans, K. / Ukena, D. / Thiele, K. P. / Neubauer, A. / Wolf, M. P. et al. | 2000
- 126
-
Multimodality treatment of lung adenocarcinomaYaskevich, L. S. / Krutilina, N. I. / Ositrova, L. I. / Davidovsky, I. V. / Shakuro, L. I. / Kostetskaya, T. V. et al. | 2000
- 126
-
Concurrent radiochemotherapy followed by surgery for stage IIIB non small cell lung cancer patients: Long-term follow-up of the CEBI 142 studyGrunenwald, D. / Andre, F. / Lepechoux, C. / Girard, P. / Tarayre, M. / Laplanche, A. / Arriagada, R. / Le Chevalier, T. et al. | 2000
- 129
-
Omento-myoplasty for post surgical pleural fistulaGiovanni, M. / Furlan, G. / Politi, L. / Terzi, A. / Lonardoni, A. / Calabro, F. et al. | 2000
- 129
-
Paravertebral, extrapleural infusion for the management of post-thoracotomy painBimston, D. / McGee, J. P. / Liptay, M. / Fry, W. et al. | 2000
- 129
-
Pulmonary function changes after induction chemotherapy with cisplatinum and gemcitabine in stage III non small cell lung cancer. Any additional risk for surgery?Leo, F. / Solli, P. / Veronesi, G. / D'Aiuto, M. / Ratcliffe, C. / D'Ovidio, F. / Pastorino, U. et al. | 2000
- 130
-
Metachronous second primary lung cancer after bronchial sleeve resectionVan Schil, P. E. / Vankeirsblick, J. / Brutel de la Riviere, A. / Knaepen, P. J. / van Swieten, H. A. / Vanderschueren, R. G. / van den Bosch, J. M. et al. | 2000
- 130
-
Carcinoid tumors of the lung. A review of 98 casesVieira, V. M. / Felix, F. / Moreira, E. / Nunes, A. C. / Mendes, I. / Serodio, J. / Pinto Marques, A. / Batista, C. / Ramos, M. / Magalhaes Godinho, M. T. et al. | 2000
- 130
-
Long term survival for resectable small cell lung cancerCataldo, I. / Bidoli, P. / Brega Massone, P. P. / Conti, B. / Lequaglie, C. et al. | 2000
- 130
-
Bronchoscopic argon plasma coagulation for tracheobronchial lesionsOkada, S. / Yamauchi, H. / Ishimori, S. / Satoh, S. et al. | 2000
- 131
-
Lung cancer and tuberculosis: Coexistance, surgical treatment and our resultsSilins, I. / Apsvalks, M. / Sirgeda, A. / Leimans, J. et al. | 2000
- 131
-
Clinical trial of limited resection for probable in situ adenocarcinoma in the lung periphery: Initial experience during the first two yearsYoshida, J. / Nagai, K. / Takahashi, K. / Nishimura, M. / Yokose, T. / Nishiwaki, Y. et al. | 2000
- 131
-
Surgical treatment of stage I bronchogenic carcinomaMolins, L. / Buitrago, J. / Vidal, G. et al. | 2000
- 131
-
Thoracic radiotherapy and daily vinorelbine as radiosensitizer in locally advanced non small cell lung cancer: a phase I studyGridelli, C. / Guida, C. / Barletta, E. / Gatani, T. / Fiore, F. / Barzelloni, M. L. / Rossi, A. / de Bellis, M. / D`Aniello, R. / Scognamiglio, F. et al. | 2000
- 132
-
Stage I bronchioloalveolar carcinoma: Results of surgical treatmentBreathnach, O. S. / Kwiatkowski, D. J. / Godleski, J. J. / Finkelstein, D. / Sugarbaker, D. J. / Johnson, B. E. / Mentzer, S. J. et al. | 2000
- 132
-
Response rate and toxicity of pre-operative paclitaxel (P) and carboplatin (C) in patients with resectable non-small cell lung cancer: A North Central Cancer Treatment Group (NCCTG) StudyMarks, R. S. / Stella, P. J. / Streitz, J. M. / Mahoney, M. R. / Deschamps, C. et al. | 2000
- 132
-
Nonresectability and extended resection in locally advanced lung cancerAkopov, A. / Levashev, Y. et al. | 2000
- 132
-
Inter-observer variability in systematic nodal dissection: A comparison of European and Japanese nodal designationWatanabe, S. / Ladas, G. / Goldstraw, P. et al. | 2000
- 133
-
Survival of lung cancer according to the 1997 pathological TNM classification in a multicenter experience in SpainRami-Porta, R. et al. | 2000
- 133
-
Prognostic value of unsuspected microresidual tumor at the resection margin. Residual disease: To be afraid or not?Lequaglie, C. / Brega Massone, P. P. / Giudice, G. / Conti, B. / Cataldo, I. et al. | 2000
- 133
-
Tumor size and clinical factors in prognosis of lung cancer. Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S)Lopez-Encuentra, A. et al. | 2000
- 133
-
Biological prognostic factors for early stage completely resected non-small cell lung cancerDarwish, S. / Bellezza, G. / Sidoni, A. / Bucciarelli, E. / Monacelli, M. / Giustozzi, G. / Ludovini, V. / Pistola, L. / Gregorc, V. / Tonato, M. et al. | 2000
- 134
-
The analysis of the risk factors of the recurrence following the resection of the NSCLC and the influence of the post-operative treatment on the survivalDziedzic, D. / Orlowski, T. M. / Sawicka-Chitryn, E. / Rudzinski, P. et al. | 2000
- 134
-
Expression of E-cadherin, alpha-, beta-, gamma-catenin in surgically-resected small-sized (3 cm or less) non-small cell lung cancersLee, Y. / Wu, C. / Chang, Y. / Chen, J. et al. | 2000
- 134
-
Surgically resected nodules whose diameter were equal or less than 10 mmNagahiro, I. / Date, H. / Anodou, A. / Shimizu, N. / Ichiba, S. / Aoe, M. / Sano, Y. et al. | 2000
- 135
-
Southern blot analysis for the allelic deletion of nm23 genes in human lung cancerZhou, Q. H. / Chen, J. / Sun, Z. L. / Qing, Y. / Liu, L. X. et al. | 2000
- 135
-
Tracheal sleeve and superior vena cava resection for bronchogenic carcinomaSpaggiari, L. / Solli, P. / Leo, F. / Veronesi, G. / D'Ovidio, F. / D'Aiuto, M. / Pastorino, U. et al. | 2000
- 135
-
Mortality after pneumonectomy in patients with lung cancer and known cardiac diseaseDuque, J. L. et al. | 2000
- 135
-
Surgery for malignancy of trachea carina and main bronchus (An analysis of 269 cases)Wu, Z. F. / Chen, H. Z. et al. | 2000
- 136
-
Perioperation's management of bronchoplastic lobectomy in lung cancerZhi, X. Y. et al. | 2000
- 136
-
Extended resection of the left atrium, great vessels, or both for locally advanced lung cancer: An experience of 248 casesZhou, Q. H. / Liu, L. X. / Wang, Y. / Zhang, H. B. / Yang, J. J. / Yang, Z. H. et al. | 2000
- 136
-
Bronchoplastic procedures after induction chemo/radiation therapyVeronesi, G. / Solli, P. / Leo, F. / Ratcliffe, C. / D'Ovidio, F. / D'Aiuto, M. / Spaggiari, L. / Pastorino, U. et al. | 2000
- 136
-
Special patterns of tracheobronchoplastic operation for lung cancerHuang, Z. et al. | 2000
- 137
-
Comparison of nodal metastasis between clinical and pathological diagnosis in primary lung cancerSohara, Y. / Murayama, F. / Endo, S. / Yamaguchi, T. / Hasegawa, T. / Teduka, K. / Saito, N. et al. | 2000
- 137
-
10-year experience of lung cancer treatment in the Krasnodar Regional Thoracic Surgery centerPoliakov, I. S. / Porhanov, V. A. / Kononenko, V. B. / Semendiaev, S. S. / Mamelov, M. U. / Bodnia, V. N. / Mezeria, A. L. et al. | 2000
- 137
-
Skip metastasis to the mediastinal lymph nodes in NSCLCWang, S. y. / Wu, Y. I. / Ou, W. / Yang, X. n. et al. | 2000
- 137
-
The importance of systematic mediastinal lymphadenectomy in resectable non-small Cell Lung Cancer - Results of a prospective randomized trialWu, Y. I. / Wang, S. y. / Huang, Z. f. / Yang, X. n. / Ou, W. / Yu, H. et al. | 2000
- 138
-
Intraoperative radioisotope sentinel lymph node mapping in Non-Small Cell Lung CancerLiptay, M. J. / Masters, G. A. / Freed, B. H. / Bakshy, A. G. et al. | 2000
- 138
-
Limited lymph node dissection in compromised patients of non-small cell lung cancerAkamine, S. / Oka, T. / Takahashi, T. / Nagayasu, T. / Muraoka, M. / Morinaga, M. / Sawada, T. / Tagawa, Y. / Ayabe, H. et al. | 2000
- 138
-
Effectiveness of Daniel's biopsy and mediastinoscopy in the treatment of primary lung cancerKoshiishi, Y. / Miya, T. / Sato, K. / Watanabe, K. / Fukushima, J. / Ono, Y. / Goya, T. et al. | 2000
- 138
-
Peroperative detection of the sentinel lymph node in non-small cell lung cancer with radioisotopic and blue dye techniqueTiffet, O. / Davies, G. / Genc, O. / Nicholson, A. G. / Ladas, G. / Underwood, R. / Goldstraw, P. et al. | 2000
- 139
-
En bloc chest wall resection for peripheral lung cancerBrega Massone, P. P. / Lequaglie, C. / Conti, B. / Magnani, B. / Cataldo, I. et al. | 2000
- 139
-
Surgery for primary and metastatic malignant chest wall tumorsPoliakov, I. S. / Porhanov, V. A. / Kononenko, V. B. / Semendiaev, S. S. / Mamelov, M. U. / Bodnia, V. N. et al. | 2000
- 139
-
Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapyChen, Y. M. / Perng, R. P. / Yang, K. Y. / Lin, W. C. / Wu, H. W. / Tsai, C. M. / Whang-Peng, J. et al. | 2000
- 139
-
Identification of the sentinel lymph node by staining in lung cancer patientsSugi, K. / Kaneda, Y. / Esato, K. et al. | 2000
- 139
-
Preoperative concurrent chemoradiotherapy for invading apical lung cancerMiyoshi, S. / Iuchi, K. / Nakamura, K. / Nakagawa, K. / Maeda, H. / Nakahara, K. / Ohno, K. / Nakano, N. / Matsuda, H. et al. | 2000
- 140
-
Surgical results for T4 lung cancerRea, F. / Bortolotti, L. / Grapeggia, M. / Zuin, A. / Michelon, M. / Gobbi, T. / Sartori, F. et al. | 2000
- 140
-
Simultaneous operations in lung cancer surgeryGuerassimov, S. / Davydov, M. / Akchurin, R. / Stilidi, I. / Machaladze, Z. / Polotsky, B. / Ungeadze, G. et al. | 2000
- 140
-
Completion pneumonectomy for lung cancerXin Gao, C. / Huang, O. et al. | 2000
- 140
-
Intrapulmonary metastasis (new T4) of non-small cell lung cancer. A prognostic assessmentOkumura, T. / Asamura, H. / Suzuki, K. / Kondo, H. / Tsuchiya, R. et al. | 2000
- 141
-
Anatomical segmentectomy for peripheral non-small cell lung cancersNakajima, Y. / Shiraishi, Y. / Takasuna, K. / Katsuragi, N. / Yoshida, S. et al. | 2000
- 141
-
Bronchoplastic segmentectomy for hilar lung cancerOka, T. / Sawada, T. / Muraoka, M. / Nagayasu, T. / Akamine, S. / Takahashi, T. / Tagawa, Y. / Ayabe, H. et al. | 2000
- 141
-
Video-assisted thoracoscopic surgery for lung cancer - Experience in Okayama UniversityAoe, M. / Andou, A. / Date, H. / Shimizu, N. / Nagahiro, I. / Ichiba, S. / Yoshihumi, S. et al. | 2000
- 141
-
Tumor angiogenesis and small cell lung cancerChella, A. / Lucchi, M. / Fontanini, G. / Basolo, F. / Mussi, A. / Angeletti, C. A. et al. | 2000
- 142
-
Homeostasis networks in prognosis of lung cancer patients survivalKshivets, O. et al. | 2000
- 142
-
Is video-assisted thoracoscopic procedure suitable for pulmonary metastasectomy?Hara, S. / Hirohata, T. / Minami, K. / Yasutomi, M. et al. | 2000
- 142
-
Surgery for lung cancer coexistence with pulmonary tuberculosisBusroh, I. D. et al. | 2000
- 142
-
Clinical predictors of minimally invasive peripheral adenocarcinoma of the lung: Possible indications for limited surgical resectionSuzuki, K. / Asamura, H. / Kondo, H. / Kusumoto, M. / Tsuchiya, R. et al. | 2000
- 143
-
Solitary fibrous tumor of the pleura: A report of 3 cases with immunohistochemical studyKita, Y. / Nogimura, H. / Kageyama, Y. / Ohi, S. / Suzuki, K. / Kazui, T. et al. | 2000
- 143
-
Non-rib-spreading formal thoracotomy for lung cancersChung, S. S. / Lo, C. K. / Ho, K. K. / Ma, C. C. et al. | 2000
- 143
-
Diagnosis & treatment of 12 cases of pneumonic carcinoma characterized by pericardial effusion as first symptomKai, Z. et al. | 2000
- 143
-
Thymomas in Myasthenia gravis (MG)Menga, G. / Rosenberg, M. / Olmedo, G. / Poleri, C. / Rey, L. / Rojas, O. / Abdala, O. et al. | 2000
- 143
-
Surgico-therapy for lung cancer at the National Institute for Tuberculosis And Respiratory Diseases, Hanoi, VietnamDung, T. T. / Co, N. V. / Anh, P. T. et al. | 2000
- 144
-
Pulmonary resection combined with volume reduction for patients with lung cancer and severe emphysemaJiaan, D. / Gening, J. / Xiao, Z. et al. | 2000
- 144
-
Bronchoplastic procedures and pulmonary artery reconstruction for centrally locatd lung cnacer: A report of 134 casesZhou, Q. H. / Liu, L. X. / Qing, Y. / Yang, J. J. / Zhang, H. B. / Yang, Z. H. et al. | 2000
- 144
-
Pulmonary artery reconstruction in the treatment of central type lung cancinoma in elderly patientsChen, H. Z. / Wu, J. F. et al. | 2000
- 145
-
Surgical treatment of lung cancer for elderly patientsZongren, G. / Mingyao, C. / Shen, W. et al. | 2000